Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for PLAGL1
Z-value: 4.10
Motif logo
Transcription factors associated with PLAGL1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
PLAGL1
|
ENSG00000118495.14 | PLAG1 like zinc finger 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| PLAGL1 | hg19_v2_chr6_-_144329531_144329546 | -0.47 | 3.4e-02 | Click! |
Activity profile of PLAGL1 motif
Sorted Z-values of PLAGL1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_+_55795493 | 12.46 |
ENST00000309383.1
|
BRSK1
|
BR serine/threonine kinase 1 |
| chr11_+_1244288 | 11.85 |
ENST00000529681.1
ENST00000447027.1 |
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming |
| chr19_+_2249308 | 11.62 |
ENST00000592877.1
ENST00000221496.4 |
AMH
|
anti-Mullerian hormone |
| chr12_+_52445191 | 11.05 |
ENST00000243050.1
ENST00000394825.1 ENST00000550763.1 ENST00000394824.2 ENST00000548232.1 ENST00000562373.1 |
NR4A1
|
nuclear receptor subfamily 4, group A, member 1 |
| chr2_+_42275153 | 8.95 |
ENST00000294964.5
|
PKDCC
|
protein kinase domain containing, cytoplasmic |
| chr19_-_460996 | 8.62 |
ENST00000264554.6
|
SHC2
|
SHC (Src homology 2 domain containing) transforming protein 2 |
| chr14_-_21566731 | 8.10 |
ENST00000360947.3
|
ZNF219
|
zinc finger protein 219 |
| chr11_-_568369 | 7.34 |
ENST00000534540.1
ENST00000528245.1 ENST00000500447.1 ENST00000533920.1 |
MIR210HG
|
MIR210 host gene (non-protein coding) |
| chr2_+_240323439 | 7.32 |
ENST00000428471.1
ENST00000413029.1 |
AC062017.1
|
Uncharacterized protein |
| chr12_-_117537240 | 6.88 |
ENST00000392545.4
ENST00000541210.1 ENST00000335209.7 |
TESC
|
tescalcin |
| chr9_+_135037334 | 6.33 |
ENST00000393229.3
ENST00000360670.3 ENST00000393228.4 ENST00000372179.3 |
NTNG2
|
netrin G2 |
| chr10_-_95360983 | 6.31 |
ENST00000371464.3
|
RBP4
|
retinol binding protein 4, plasma |
| chr17_+_27895609 | 6.31 |
ENST00000581411.2
ENST00000301057.7 |
TP53I13
|
tumor protein p53 inducible protein 13 |
| chr3_-_158450475 | 6.26 |
ENST00000237696.5
|
RARRES1
|
retinoic acid receptor responder (tazarotene induced) 1 |
| chr19_+_16435625 | 6.20 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
| chr19_-_33793430 | 6.20 |
ENST00000498907.2
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha |
| chr19_+_5914213 | 6.16 |
ENST00000222125.5
ENST00000452990.2 ENST00000588865.1 |
CAPS
|
calcyphosine |
| chr19_+_589893 | 6.11 |
ENST00000251287.2
|
HCN2
|
hyperpolarization activated cyclic nucleotide-gated potassium channel 2 |
| chr19_-_1592652 | 5.89 |
ENST00000156825.1
ENST00000434436.3 |
MBD3
|
methyl-CpG binding domain protein 3 |
| chr14_-_21567009 | 5.69 |
ENST00000556174.1
ENST00000554478.1 ENST00000553980.1 ENST00000421093.2 |
ZNF219
|
zinc finger protein 219 |
| chr22_-_50970506 | 5.67 |
ENST00000428989.2
ENST00000403326.1 |
ODF3B
|
outer dense fiber of sperm tails 3B |
| chr19_+_54466179 | 5.64 |
ENST00000270458.2
|
CACNG8
|
calcium channel, voltage-dependent, gamma subunit 8 |
| chr1_+_33722080 | 5.62 |
ENST00000483388.1
ENST00000539719.1 |
ZNF362
|
zinc finger protein 362 |
| chr1_-_32801825 | 5.47 |
ENST00000329421.7
|
MARCKSL1
|
MARCKS-like 1 |
| chr7_-_139876812 | 5.45 |
ENST00000397560.2
|
JHDM1D
|
lysine (K)-specific demethylase 7A |
| chr11_+_842808 | 5.42 |
ENST00000397397.2
ENST00000397411.2 ENST00000397396.1 |
TSPAN4
|
tetraspanin 4 |
| chr1_+_874649 | 5.40 |
ENST00000455979.1
|
SAMD11
|
sterile alpha motif domain containing 11 |
| chr19_+_859654 | 5.36 |
ENST00000592860.1
|
CFD
|
complement factor D (adipsin) |
| chr16_+_1203194 | 5.33 |
ENST00000348261.5
ENST00000358590.4 |
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
| chr19_+_47523058 | 5.30 |
ENST00000602212.1
ENST00000602189.1 |
NPAS1
|
neuronal PAS domain protein 1 |
| chr19_-_18391708 | 5.30 |
ENST00000600972.1
|
JUND
|
jun D proto-oncogene |
| chr8_-_145115584 | 5.22 |
ENST00000426825.1
|
OPLAH
|
5-oxoprolinase (ATP-hydrolysing) |
| chr8_+_144451039 | 5.18 |
ENST00000289013.6
|
RHPN1
|
rhophilin, Rho GTPase binding protein 1 |
| chr11_+_64009072 | 5.17 |
ENST00000535135.1
ENST00000394540.3 |
FKBP2
|
FK506 binding protein 2, 13kDa |
| chr8_+_145490549 | 5.11 |
ENST00000340695.2
|
SCXA
|
scleraxis homolog A (mouse) |
| chr11_+_64001962 | 5.10 |
ENST00000309422.2
|
VEGFB
|
vascular endothelial growth factor B |
| chr19_-_3029011 | 5.05 |
ENST00000590536.1
ENST00000587137.1 ENST00000455444.2 ENST00000262953.6 |
TLE2
|
transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) |
| chr19_+_2977444 | 5.05 |
ENST00000246112.4
ENST00000453329.1 ENST00000482627.1 ENST00000452088.1 |
TLE6
|
transducin-like enhancer of split 6 (E(sp1) homolog, Drosophila) |
| chr22_+_29279552 | 4.94 |
ENST00000544604.2
|
ZNRF3
|
zinc and ring finger 3 |
| chrX_-_153707545 | 4.93 |
ENST00000357360.4
|
LAGE3
|
L antigen family, member 3 |
| chr22_+_48972118 | 4.93 |
ENST00000358295.5
|
FAM19A5
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A5 |
| chr11_-_117695449 | 4.92 |
ENST00000292079.2
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chr12_+_58005204 | 4.90 |
ENST00000286494.4
|
ARHGEF25
|
Rho guanine nucleotide exchange factor (GEF) 25 |
| chr1_-_935361 | 4.86 |
ENST00000484667.2
|
HES4
|
hes family bHLH transcription factor 4 |
| chr20_+_61867235 | 4.84 |
ENST00000342412.6
ENST00000217169.3 |
BIRC7
|
baculoviral IAP repeat containing 7 |
| chr20_+_4129426 | 4.83 |
ENST00000339123.6
ENST00000305958.4 ENST00000278795.3 |
SMOX
|
spermine oxidase |
| chr9_-_140009130 | 4.80 |
ENST00000497375.1
ENST00000371579.2 |
DPP7
|
dipeptidyl-peptidase 7 |
| chr14_+_102027688 | 4.80 |
ENST00000510508.4
ENST00000359323.3 |
DIO3
|
deiodinase, iodothyronine, type III |
| chr8_+_142402089 | 4.74 |
ENST00000521578.1
ENST00000520105.1 ENST00000523147.1 |
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3 |
| chr1_+_840205 | 4.64 |
ENST00000607769.1
|
RP11-54O7.16
|
RP11-54O7.16 |
| chr4_+_980785 | 4.61 |
ENST00000247933.4
ENST00000453894.1 |
IDUA
|
iduronidase, alpha-L- |
| chr20_-_60942361 | 4.60 |
ENST00000252999.3
|
LAMA5
|
laminin, alpha 5 |
| chr7_+_99971068 | 4.60 |
ENST00000198536.2
ENST00000453419.1 |
PILRA
|
paired immunoglobin-like type 2 receptor alpha |
| chr11_+_844067 | 4.60 |
ENST00000397406.1
ENST00000409543.2 ENST00000525201.1 |
TSPAN4
|
tetraspanin 4 |
| chr19_-_10047219 | 4.59 |
ENST00000264833.4
|
OLFM2
|
olfactomedin 2 |
| chr6_+_7727030 | 4.57 |
ENST00000283147.6
|
BMP6
|
bone morphogenetic protein 6 |
| chr4_+_668348 | 4.52 |
ENST00000511290.1
|
MYL5
|
myosin, light chain 5, regulatory |
| chr19_+_13261216 | 4.49 |
ENST00000587885.1
ENST00000292433.3 |
IER2
|
immediate early response 2 |
| chr11_+_313503 | 4.46 |
ENST00000528780.1
ENST00000328221.5 |
IFITM1
|
interferon induced transmembrane protein 1 |
| chr11_-_615570 | 4.45 |
ENST00000525445.1
ENST00000348655.6 ENST00000397566.1 |
IRF7
|
interferon regulatory factor 7 |
| chr14_+_105559784 | 4.42 |
ENST00000548104.1
|
RP11-44N21.1
|
RP11-44N21.1 |
| chr11_-_559377 | 4.41 |
ENST00000486629.1
|
C11orf35
|
chromosome 11 open reading frame 35 |
| chr1_-_3528034 | 4.41 |
ENST00000356575.4
|
MEGF6
|
multiple EGF-like-domains 6 |
| chr12_-_58131931 | 4.40 |
ENST00000547588.1
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
| chr11_+_64052692 | 4.40 |
ENST00000377702.4
|
GPR137
|
G protein-coupled receptor 137 |
| chr11_+_64008443 | 4.38 |
ENST00000309366.4
|
FKBP2
|
FK506 binding protein 2, 13kDa |
| chr16_+_89642120 | 4.35 |
ENST00000268720.5
ENST00000319518.8 |
CPNE7
|
copine VII |
| chr9_+_139847347 | 4.34 |
ENST00000371632.3
|
LCN12
|
lipocalin 12 |
| chr19_-_51014460 | 4.33 |
ENST00000595669.1
|
JOSD2
|
Josephin domain containing 2 |
| chr7_-_72439997 | 4.31 |
ENST00000285805.3
|
TRIM74
|
tripartite motif containing 74 |
| chr11_+_64002292 | 4.31 |
ENST00000426086.2
|
VEGFB
|
vascular endothelial growth factor B |
| chr22_-_51016846 | 4.30 |
ENST00000312108.7
ENST00000395650.2 |
CPT1B
|
carnitine palmitoyltransferase 1B (muscle) |
| chr4_+_980825 | 4.30 |
ENST00000502910.1
ENST00000504568.1 |
IDUA
|
iduronidase, alpha-L- |
| chr20_-_39995467 | 4.28 |
ENST00000332312.3
|
EMILIN3
|
elastin microfibril interfacer 3 |
| chr21_+_47518011 | 4.27 |
ENST00000300527.4
ENST00000357838.4 ENST00000310645.5 |
COL6A2
|
collagen, type VI, alpha 2 |
| chr16_+_577697 | 4.25 |
ENST00000562370.1
ENST00000568988.1 ENST00000219611.2 |
CAPN15
|
calpain 15 |
| chr17_+_36861735 | 4.24 |
ENST00000378137.5
ENST00000325718.7 |
MLLT6
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 |
| chr19_+_33685490 | 4.22 |
ENST00000253193.7
|
LRP3
|
low density lipoprotein receptor-related protein 3 |
| chr7_+_73082152 | 4.21 |
ENST00000324941.4
ENST00000451519.1 |
VPS37D
|
vacuolar protein sorting 37 homolog D (S. cerevisiae) |
| chr19_-_18392422 | 4.21 |
ENST00000252818.3
|
JUND
|
jun D proto-oncogene |
| chr3_-_158450231 | 4.20 |
ENST00000479756.1
|
RARRES1
|
retinoic acid receptor responder (tazarotene induced) 1 |
| chr6_-_29595779 | 4.15 |
ENST00000355973.3
ENST00000377012.4 |
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1 |
| chr3_-_129035120 | 4.14 |
ENST00000333762.4
|
H1FX
|
H1 histone family, member X |
| chr2_+_219724544 | 4.09 |
ENST00000233948.3
|
WNT6
|
wingless-type MMTV integration site family, member 6 |
| chr11_-_67141090 | 4.09 |
ENST00000312438.7
|
CLCF1
|
cardiotrophin-like cytokine factor 1 |
| chr9_-_19127474 | 4.08 |
ENST00000380465.3
ENST00000380464.3 ENST00000411567.1 ENST00000276914.2 |
PLIN2
|
perilipin 2 |
| chr16_+_2076869 | 4.07 |
ENST00000424542.2
ENST00000432365.2 |
SLC9A3R2
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 |
| chr1_+_8378140 | 4.06 |
ENST00000377479.2
|
SLC45A1
|
solute carrier family 45, member 1 |
| chr1_-_222721434 | 4.04 |
ENST00000343410.6
|
HHIPL2
|
HHIP-like 2 |
| chr19_-_1592828 | 4.04 |
ENST00000592012.1
|
MBD3
|
methyl-CpG binding domain protein 3 |
| chr7_-_1609591 | 4.03 |
ENST00000288607.2
ENST00000404674.3 |
PSMG3
|
proteasome (prosome, macropain) assembly chaperone 3 |
| chr16_+_699319 | 4.02 |
ENST00000549091.1
ENST00000293879.4 |
WDR90
|
WD repeat domain 90 |
| chr8_-_145691031 | 4.01 |
ENST00000424149.2
ENST00000530637.1 ENST00000306145.5 |
CYHR1
|
cysteine/histidine-rich 1 |
| chr19_-_46272462 | 4.01 |
ENST00000317578.6
|
SIX5
|
SIX homeobox 5 |
| chr11_+_64008525 | 4.01 |
ENST00000449942.2
|
FKBP2
|
FK506 binding protein 2, 13kDa |
| chr5_-_179780312 | 4.00 |
ENST00000253778.8
|
GFPT2
|
glutamine-fructose-6-phosphate transaminase 2 |
| chr19_+_45418067 | 3.97 |
ENST00000589078.1
ENST00000586638.1 |
APOC1
|
apolipoprotein C-I |
| chr20_+_4129496 | 3.97 |
ENST00000346595.2
|
SMOX
|
spermine oxidase |
| chr2_+_71162995 | 3.96 |
ENST00000234396.4
|
ATP6V1B1
|
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 |
| chr11_+_66045634 | 3.94 |
ENST00000528852.1
ENST00000311445.6 |
CNIH2
|
cornichon family AMPA receptor auxiliary protein 2 |
| chr8_+_145133493 | 3.93 |
ENST00000316052.5
ENST00000525936.1 |
EXOSC4
|
exosome component 4 |
| chr19_+_827823 | 3.93 |
ENST00000233997.2
|
AZU1
|
azurocidin 1 |
| chr1_-_3447967 | 3.92 |
ENST00000294599.4
|
MEGF6
|
multiple EGF-like-domains 6 |
| chr5_+_1008910 | 3.90 |
ENST00000296849.5
ENST00000274150.4 ENST00000537972.1 |
NKD2
|
naked cuticle homolog 2 (Drosophila) |
| chr3_+_126243126 | 3.89 |
ENST00000319340.2
|
CHST13
|
carbohydrate (chondroitin 4) sulfotransferase 13 |
| chr20_+_48807351 | 3.87 |
ENST00000303004.3
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta |
| chr14_+_105992906 | 3.87 |
ENST00000392519.2
|
TMEM121
|
transmembrane protein 121 |
| chr2_+_220306745 | 3.87 |
ENST00000431523.1
ENST00000396698.1 ENST00000396695.2 |
SPEG
|
SPEG complex locus |
| chr8_-_145582118 | 3.85 |
ENST00000455319.2
ENST00000331890.5 |
FBXL6
|
F-box and leucine-rich repeat protein 6 |
| chr11_+_64879317 | 3.85 |
ENST00000526809.1
ENST00000279263.7 ENST00000524986.1 ENST00000534371.1 ENST00000540748.1 ENST00000525385.1 ENST00000345348.5 ENST00000531321.1 ENST00000529414.1 ENST00000526085.1 ENST00000530750.1 |
TM7SF2
|
transmembrane 7 superfamily member 2 |
| chr16_-_88717482 | 3.84 |
ENST00000261623.3
|
CYBA
|
cytochrome b-245, alpha polypeptide |
| chrX_+_51928002 | 3.84 |
ENST00000375626.3
|
MAGED4
|
melanoma antigen family D, 4 |
| chr19_+_45971246 | 3.82 |
ENST00000585836.1
ENST00000417353.2 ENST00000353609.3 ENST00000591858.1 ENST00000443841.2 ENST00000590335.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
| chr14_-_92413727 | 3.81 |
ENST00000267620.10
|
FBLN5
|
fibulin 5 |
| chr19_-_56092187 | 3.79 |
ENST00000325421.4
ENST00000592239.1 |
ZNF579
|
zinc finger protein 579 |
| chr9_-_33402506 | 3.79 |
ENST00000377425.4
ENST00000537089.1 ENST00000297988.1 ENST00000539936.1 ENST00000541274.1 |
AQP7
|
aquaporin 7 |
| chr19_-_51071302 | 3.78 |
ENST00000389201.3
ENST00000600381.1 |
LRRC4B
|
leucine rich repeat containing 4B |
| chr16_-_2205352 | 3.78 |
ENST00000563192.1
|
RP11-304L19.5
|
RP11-304L19.5 |
| chr14_+_75745477 | 3.78 |
ENST00000303562.4
ENST00000554617.1 ENST00000554212.1 ENST00000535987.1 ENST00000555242.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
| chr11_-_615942 | 3.77 |
ENST00000397562.3
ENST00000330243.5 ENST00000397570.1 ENST00000397574.2 |
IRF7
|
interferon regulatory factor 7 |
| chr9_+_139560197 | 3.76 |
ENST00000371698.3
|
EGFL7
|
EGF-like-domain, multiple 7 |
| chr13_-_110438914 | 3.74 |
ENST00000375856.3
|
IRS2
|
insulin receptor substrate 2 |
| chr2_+_71163051 | 3.74 |
ENST00000412314.1
|
ATP6V1B1
|
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 |
| chr19_-_44124019 | 3.74 |
ENST00000300811.3
|
ZNF428
|
zinc finger protein 428 |
| chr12_+_52450298 | 3.73 |
ENST00000550582.2
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1 |
| chr14_-_23791484 | 3.72 |
ENST00000594872.1
|
AL049829.1
|
Uncharacterized protein |
| chr17_-_46724186 | 3.70 |
ENST00000433510.2
|
RP11-357H14.17
|
RP11-357H14.17 |
| chr14_+_70346125 | 3.68 |
ENST00000361956.3
ENST00000381280.4 |
SMOC1
|
SPARC related modular calcium binding 1 |
| chr19_+_56111680 | 3.68 |
ENST00000301073.3
|
ZNF524
|
zinc finger protein 524 |
| chr22_+_20119320 | 3.68 |
ENST00000334554.7
ENST00000320602.7 ENST00000405930.3 |
ZDHHC8
|
zinc finger, DHHC-type containing 8 |
| chr17_-_46894576 | 3.67 |
ENST00000393382.3
|
TTLL6
|
tubulin tyrosine ligase-like family, member 6 |
| chr19_-_50370799 | 3.67 |
ENST00000600910.1
ENST00000322344.3 ENST00000600573.1 |
PNKP
|
polynucleotide kinase 3'-phosphatase |
| chr22_-_38484922 | 3.66 |
ENST00000428572.1
|
BAIAP2L2
|
BAI1-associated protein 2-like 2 |
| chr20_-_61885826 | 3.64 |
ENST00000370316.3
|
NKAIN4
|
Na+/K+ transporting ATPase interacting 4 |
| chr1_+_45140360 | 3.63 |
ENST00000418644.1
ENST00000458657.2 ENST00000441519.1 ENST00000535358.1 ENST00000445071.1 |
C1orf228
|
chromosome 1 open reading frame 228 |
| chr7_+_100081542 | 3.63 |
ENST00000300179.2
ENST00000423930.1 |
NYAP1
|
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 1 |
| chr19_+_45251804 | 3.62 |
ENST00000164227.5
|
BCL3
|
B-cell CLL/lymphoma 3 |
| chr19_+_51815102 | 3.61 |
ENST00000270642.8
|
IGLON5
|
IgLON family member 5 |
| chr8_+_145321517 | 3.61 |
ENST00000340210.1
|
SCXB
|
scleraxis homolog B (mouse) |
| chr20_-_34542548 | 3.58 |
ENST00000305978.2
|
SCAND1
|
SCAN domain containing 1 |
| chr19_+_55888186 | 3.58 |
ENST00000291934.3
|
TMEM190
|
transmembrane protein 190 |
| chr19_-_36342739 | 3.58 |
ENST00000378910.5
ENST00000353632.6 |
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin) |
| chr16_-_1020849 | 3.57 |
ENST00000568897.1
|
LMF1
|
lipase maturation factor 1 |
| chr19_+_40697514 | 3.56 |
ENST00000253055.3
|
MAP3K10
|
mitogen-activated protein kinase kinase kinase 10 |
| chr4_+_2043689 | 3.55 |
ENST00000382878.3
ENST00000409248.4 |
C4orf48
|
chromosome 4 open reading frame 48 |
| chr8_+_145597713 | 3.55 |
ENST00000308860.6
ENST00000532190.1 |
ADCK5
|
aarF domain containing kinase 5 |
| chr19_+_782755 | 3.55 |
ENST00000606242.1
ENST00000586061.1 |
AC006273.5
|
AC006273.5 |
| chr7_-_100171270 | 3.55 |
ENST00000538735.1
|
SAP25
|
Sin3A-associated protein, 25kDa |
| chr19_+_12902289 | 3.53 |
ENST00000302754.4
|
JUNB
|
jun B proto-oncogene |
| chr19_-_14201776 | 3.53 |
ENST00000269724.5
|
SAMD1
|
sterile alpha motif domain containing 1 |
| chr8_+_144349606 | 3.53 |
ENST00000521682.1
ENST00000340042.1 |
GLI4
|
GLI family zinc finger 4 |
| chr15_+_89182156 | 3.51 |
ENST00000379224.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
| chr11_-_46142948 | 3.51 |
ENST00000257821.4
|
PHF21A
|
PHD finger protein 21A |
| chr19_-_51014345 | 3.51 |
ENST00000391815.3
ENST00000594350.1 ENST00000601423.1 |
JOSD2
|
Josephin domain containing 2 |
| chr19_+_507299 | 3.50 |
ENST00000359315.5
|
TPGS1
|
tubulin polyglutamylase complex subunit 1 |
| chr11_+_57227981 | 3.50 |
ENST00000335099.3
|
RTN4RL2
|
reticulon 4 receptor-like 2 |
| chr22_-_20792089 | 3.50 |
ENST00000405555.3
ENST00000266214.5 |
SCARF2
|
scavenger receptor class F, member 2 |
| chr16_+_2198604 | 3.50 |
ENST00000210187.6
|
RAB26
|
RAB26, member RAS oncogene family |
| chr19_+_46367518 | 3.50 |
ENST00000302177.2
|
FOXA3
|
forkhead box A3 |
| chr20_-_62129163 | 3.49 |
ENST00000298049.7
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
| chr16_+_777246 | 3.47 |
ENST00000561546.1
ENST00000564545.1 ENST00000389703.3 ENST00000567414.1 ENST00000568141.1 |
HAGHL
|
hydroxyacylglutathione hydrolase-like |
| chr22_-_45559540 | 3.47 |
ENST00000432502.1
|
CTA-217C2.1
|
CTA-217C2.1 |
| chr12_+_7023491 | 3.46 |
ENST00000541477.1
ENST00000229277.1 |
ENO2
|
enolase 2 (gamma, neuronal) |
| chr11_+_308143 | 3.46 |
ENST00000399817.4
|
IFITM2
|
interferon induced transmembrane protein 2 |
| chr15_-_74495188 | 3.44 |
ENST00000563965.1
ENST00000395105.4 |
STRA6
|
stimulated by retinoic acid 6 |
| chr19_+_7710774 | 3.44 |
ENST00000602355.1
|
STXBP2
|
syntaxin binding protein 2 |
| chr19_-_51014588 | 3.44 |
ENST00000598418.1
|
JOSD2
|
Josephin domain containing 2 |
| chr20_+_36974759 | 3.42 |
ENST00000217407.2
|
LBP
|
lipopolysaccharide binding protein |
| chr11_-_63536113 | 3.42 |
ENST00000433688.1
ENST00000546282.2 |
C11orf95
RP11-466C23.4
|
chromosome 11 open reading frame 95 RP11-466C23.4 |
| chr16_-_1020954 | 3.41 |
ENST00000543238.1
ENST00000539379.1 ENST00000399843.2 ENST00000262301.11 |
LMF1
|
lipase maturation factor 1 |
| chr22_-_30956746 | 3.40 |
ENST00000437282.1
ENST00000447224.1 ENST00000427899.1 ENST00000406955.1 ENST00000452827.1 |
GAL3ST1
|
galactose-3-O-sulfotransferase 1 |
| chr1_-_935491 | 3.40 |
ENST00000304952.6
|
HES4
|
hes family bHLH transcription factor 4 |
| chr12_+_121163538 | 3.39 |
ENST00000242592.4
|
ACADS
|
acyl-CoA dehydrogenase, C-2 to C-3 short chain |
| chr4_+_3465027 | 3.39 |
ENST00000389653.2
ENST00000507039.1 ENST00000340083.5 |
DOK7
|
docking protein 7 |
| chr14_+_21566980 | 3.39 |
ENST00000418511.2
ENST00000554329.2 |
TMEM253
|
transmembrane protein 253 |
| chr16_-_29478016 | 3.39 |
ENST00000549858.1
ENST00000551411.1 |
RP11-345J4.3
|
Uncharacterized protein |
| chr3_+_184097836 | 3.39 |
ENST00000204604.1
ENST00000310236.3 |
CHRD
|
chordin |
| chr3_+_48507210 | 3.38 |
ENST00000433541.1
ENST00000422277.2 ENST00000436480.2 ENST00000444177.1 |
TREX1
|
three prime repair exonuclease 1 |
| chr17_-_43045439 | 3.38 |
ENST00000253407.3
|
C1QL1
|
complement component 1, q subcomponent-like 1 |
| chr4_+_3768075 | 3.37 |
ENST00000509482.1
ENST00000330055.5 |
ADRA2C
|
adrenoceptor alpha 2C |
| chr16_-_30023615 | 3.37 |
ENST00000564979.1
ENST00000563378.1 |
DOC2A
|
double C2-like domains, alpha |
| chr9_+_140317802 | 3.33 |
ENST00000341349.2
ENST00000392815.2 |
NOXA1
|
NADPH oxidase activator 1 |
| chr3_+_184079492 | 3.33 |
ENST00000456318.1
ENST00000412877.1 ENST00000438240.1 |
POLR2H
|
polymerase (RNA) II (DNA directed) polypeptide H |
| chr1_+_11714425 | 3.33 |
ENST00000251546.4
|
FBXO44
|
F-box protein 44 |
| chr20_+_388935 | 3.32 |
ENST00000382181.2
ENST00000400247.3 |
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1 |
| chrX_-_153095813 | 3.31 |
ENST00000544474.1
|
PDZD4
|
PDZ domain containing 4 |
| chr12_-_51611477 | 3.31 |
ENST00000389243.4
|
POU6F1
|
POU class 6 homeobox 1 |
| chr11_+_1411129 | 3.31 |
ENST00000308219.9
ENST00000528841.1 ENST00000531197.1 ENST00000308230.5 |
BRSK2
|
BR serine/threonine kinase 2 |
| chr11_-_2924720 | 3.30 |
ENST00000455942.2
|
SLC22A18AS
|
solute carrier family 22 (organic cation transporter), member 18 antisense |
| chr16_+_29817841 | 3.30 |
ENST00000322945.6
ENST00000562337.1 ENST00000566906.2 ENST00000563402.1 ENST00000219782.6 |
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr17_+_48712206 | 3.30 |
ENST00000427699.1
ENST00000285238.8 |
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
| chr12_+_49932886 | 3.30 |
ENST00000257981.6
|
KCNH3
|
potassium voltage-gated channel, subfamily H (eag-related), member 3 |
| chr16_-_1031259 | 3.30 |
ENST00000563837.1
ENST00000563863.1 ENST00000565069.1 ENST00000570014.1 |
RP11-161M6.2
LMF1
|
RP11-161M6.2 lipase maturation factor 1 |
| chr2_+_121103706 | 3.29 |
ENST00000295228.3
|
INHBB
|
inhibin, beta B |
| chr19_+_35532612 | 3.28 |
ENST00000600390.1
ENST00000597419.1 |
HPN
|
hepsin |
| chr19_+_1104415 | 3.28 |
ENST00000585362.2
|
GPX4
|
glutathione peroxidase 4 |
| chr1_+_156698743 | 3.27 |
ENST00000524343.1
|
RRNAD1
|
ribosomal RNA adenine dimethylase domain containing 1 |
| chr9_+_139846708 | 3.27 |
ENST00000371633.3
|
LCN12
|
lipocalin 12 |
| chr22_+_25003626 | 3.26 |
ENST00000451366.1
ENST00000406383.2 ENST00000428855.1 |
GGT1
|
gamma-glutamyltransferase 1 |
| chr17_+_78075498 | 3.25 |
ENST00000302262.3
|
GAA
|
glucosidase, alpha; acid |
Network of associatons between targets according to the STRING database.
First level regulatory network of PLAGL1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.9 | 11.7 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 2.9 | 11.5 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 2.5 | 7.5 | GO:0043181 | vacuolar sequestering(GO:0043181) |
| 2.3 | 2.3 | GO:0036309 | protein localization to M-band(GO:0036309) |
| 2.3 | 6.8 | GO:0050720 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) interleukin-1 beta biosynthetic process(GO:0050720) |
| 2.2 | 6.6 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 2.1 | 6.2 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 2.0 | 12.1 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 2.0 | 6.0 | GO:0007037 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 2.0 | 8.0 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 1.9 | 5.7 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 1.9 | 5.7 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 1.8 | 1.8 | GO:0090346 | cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 1.8 | 3.6 | GO:0060193 | positive regulation of lipase activity(GO:0060193) |
| 1.7 | 8.4 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 1.7 | 1.7 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 1.6 | 9.7 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 1.6 | 3.1 | GO:0035419 | activation of MAPK activity involved in innate immune response(GO:0035419) |
| 1.6 | 1.6 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
| 1.5 | 6.2 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 1.5 | 10.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 1.5 | 7.5 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 1.5 | 1.5 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 1.5 | 19.2 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 1.4 | 7.2 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 1.4 | 2.9 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 1.4 | 7.1 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 1.4 | 4.3 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 1.4 | 4.2 | GO:0035623 | renal glucose absorption(GO:0035623) |
| 1.4 | 6.8 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 1.4 | 4.1 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 1.4 | 4.1 | GO:1903410 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
| 1.4 | 6.8 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 1.3 | 4.0 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 1.3 | 1.3 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 1.3 | 9.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 1.3 | 3.9 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 1.3 | 3.8 | GO:0060927 | Purkinje myocyte differentiation(GO:0003168) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 1.3 | 1.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 1.3 | 5.1 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 1.3 | 6.4 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 1.3 | 6.3 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
| 1.2 | 6.2 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
| 1.2 | 3.7 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
| 1.2 | 1.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 1.2 | 3.6 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
| 1.2 | 4.8 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 1.2 | 4.7 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 1.2 | 3.5 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 1.2 | 6.9 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 1.1 | 5.7 | GO:0032218 | riboflavin transport(GO:0032218) |
| 1.1 | 3.4 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 1.1 | 3.3 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
| 1.1 | 3.3 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 1.1 | 6.5 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 1.1 | 3.2 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 1.1 | 3.2 | GO:0090427 | activation of meiosis(GO:0090427) |
| 1.1 | 4.2 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 1.1 | 6.3 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 1.0 | 9.4 | GO:0046618 | drug export(GO:0046618) |
| 1.0 | 3.1 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 1.0 | 6.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 1.0 | 3.1 | GO:0035284 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 1.0 | 2.0 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 1.0 | 4.1 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 1.0 | 3.0 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 1.0 | 7.0 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 1.0 | 3.0 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 1.0 | 4.9 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 1.0 | 3.0 | GO:1901207 | regulation of heart looping(GO:1901207) |
| 1.0 | 3.0 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 1.0 | 4.9 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 1.0 | 3.9 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 1.0 | 3.9 | GO:0032811 | regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) epinephrine secretion(GO:0048242) |
| 1.0 | 2.9 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 1.0 | 2.9 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 1.0 | 3.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.9 | 1.9 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
| 0.9 | 4.7 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
| 0.9 | 4.7 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.9 | 6.6 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.9 | 2.8 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.9 | 9.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.9 | 2.7 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.9 | 0.9 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.9 | 5.4 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.9 | 2.7 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.9 | 5.4 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.9 | 2.7 | GO:0090274 | regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
| 0.9 | 8.9 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.9 | 0.9 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) negative regulation of neuromuscular junction development(GO:1904397) |
| 0.9 | 3.6 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.9 | 7.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.9 | 2.7 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.9 | 13.3 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.9 | 2.7 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.9 | 5.2 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.9 | 3.5 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.9 | 13.7 | GO:0000050 | urea cycle(GO:0000050) |
| 0.8 | 1.7 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.8 | 14.8 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.8 | 0.8 | GO:0048320 | axial mesoderm formation(GO:0048320) |
| 0.8 | 2.4 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 0.8 | 2.4 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
| 0.8 | 2.4 | GO:0097195 | pilomotor reflex(GO:0097195) |
| 0.8 | 2.4 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.8 | 3.2 | GO:2001178 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.8 | 6.4 | GO:0097461 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.8 | 1.6 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.8 | 1.6 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.8 | 6.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.8 | 1.6 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.8 | 5.5 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.8 | 1.6 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.8 | 2.3 | GO:0060061 | Spemann organizer formation(GO:0060061) |
| 0.8 | 2.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.8 | 2.3 | GO:0046080 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.8 | 2.3 | GO:0052510 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.8 | 2.3 | GO:1901076 | positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 0.8 | 6.9 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.8 | 3.8 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.8 | 7.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.8 | 2.3 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.8 | 9.8 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.8 | 6.8 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.7 | 9.7 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
| 0.7 | 4.5 | GO:0043126 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.7 | 1.5 | GO:0043585 | nose morphogenesis(GO:0043585) |
| 0.7 | 0.7 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.7 | 0.7 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.7 | 2.2 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.7 | 4.4 | GO:0072218 | ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) metanephric loop of Henle development(GO:0072236) |
| 0.7 | 2.2 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
| 0.7 | 1.4 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.7 | 0.7 | GO:0070555 | response to interleukin-1(GO:0070555) |
| 0.7 | 2.8 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 0.7 | 2.1 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.7 | 2.1 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.7 | 1.4 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.7 | 2.7 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
| 0.7 | 0.7 | GO:0099504 | synaptic vesicle cycle(GO:0099504) |
| 0.7 | 2.0 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) notochord regression(GO:0060032) |
| 0.7 | 2.0 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.7 | 0.7 | GO:1902022 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
| 0.7 | 6.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.7 | 2.0 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.7 | 2.0 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.7 | 3.9 | GO:0015822 | ornithine transport(GO:0015822) |
| 0.7 | 0.7 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.7 | 1.3 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.7 | 3.3 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
| 0.6 | 5.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.6 | 5.2 | GO:0071321 | cellular response to cGMP(GO:0071321) |
| 0.6 | 3.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.6 | 1.9 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 0.6 | 3.2 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.6 | 5.7 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.6 | 2.5 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.6 | 3.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.6 | 1.8 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.6 | 2.5 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.6 | 2.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.6 | 1.2 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.6 | 1.8 | GO:1904603 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 0.6 | 2.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.6 | 2.4 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
| 0.6 | 3.0 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.6 | 1.8 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 0.6 | 1.2 | GO:0060022 | hard palate development(GO:0060022) |
| 0.6 | 2.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.6 | 1.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 0.6 | 0.6 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.6 | 2.4 | GO:1903949 | positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 0.6 | 0.6 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.6 | 2.4 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.6 | 3.0 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.6 | 1.8 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 0.6 | 1.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.6 | 0.6 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
| 0.6 | 1.8 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 0.6 | 3.5 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.6 | 2.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.6 | 1.8 | GO:2000349 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
| 0.6 | 5.8 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.6 | 0.6 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.6 | 2.9 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.6 | 10.8 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
| 0.6 | 5.7 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.6 | 2.8 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.6 | 1.7 | GO:0052330 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 0.6 | 0.6 | GO:0060629 | regulation of homologous chromosome segregation(GO:0060629) |
| 0.6 | 3.4 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 0.6 | 2.2 | GO:0052026 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.6 | 3.9 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.6 | 5.6 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
| 0.5 | 2.2 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.5 | 1.6 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
| 0.5 | 1.6 | GO:0006522 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.5 | 0.5 | GO:0030224 | monocyte differentiation(GO:0030224) |
| 0.5 | 1.6 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.5 | 1.1 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
| 0.5 | 0.5 | GO:0009447 | putrescine catabolic process(GO:0009447) polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.5 | 2.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.5 | 0.5 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
| 0.5 | 5.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.5 | 3.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.5 | 2.1 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.5 | 1.6 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.5 | 3.7 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.5 | 0.5 | GO:0071888 | macrophage apoptotic process(GO:0071888) |
| 0.5 | 2.6 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.5 | 1.6 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
| 0.5 | 2.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.5 | 2.1 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.5 | 3.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.5 | 3.5 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
| 0.5 | 1.5 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.5 | 2.0 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
| 0.5 | 2.0 | GO:0070843 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.5 | 0.5 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
| 0.5 | 4.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.5 | 1.5 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 0.5 | 2.0 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.5 | 1.5 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.5 | 1.5 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.5 | 1.5 | GO:0019516 | lactate oxidation(GO:0019516) |
| 0.5 | 10.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.5 | 1.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.5 | 0.5 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 0.5 | 1.5 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.5 | 6.9 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.5 | 1.5 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.5 | 1.5 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.5 | 1.5 | GO:0021546 | rhombomere development(GO:0021546) |
| 0.5 | 1.0 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
| 0.5 | 1.0 | GO:0097531 | mast cell migration(GO:0097531) |
| 0.5 | 5.3 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.5 | 1.4 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.5 | 1.4 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
| 0.5 | 1.4 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.5 | 0.5 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
| 0.5 | 7.6 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
| 0.5 | 2.4 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.5 | 1.9 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.5 | 1.9 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.5 | 2.8 | GO:0060426 | lung vasculature development(GO:0060426) |
| 0.5 | 1.4 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.5 | 4.2 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.5 | 1.9 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.5 | 0.5 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.5 | 1.4 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.5 | 2.3 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.5 | 1.4 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.5 | 0.5 | GO:0035038 | female pronucleus assembly(GO:0035038) |
| 0.5 | 0.9 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.5 | 1.8 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.5 | 2.3 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.5 | 2.3 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 0.5 | 2.7 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 0.4 | 1.8 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.4 | 0.9 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.4 | 1.3 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.4 | 2.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.4 | 1.8 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.4 | 0.9 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 0.4 | 5.6 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.4 | 0.4 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.4 | 5.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.4 | 4.3 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.4 | 1.3 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.4 | 5.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.4 | 0.8 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.4 | 7.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.4 | 0.8 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.4 | 1.3 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.4 | 2.5 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.4 | 2.1 | GO:0036018 | response to erythropoietin(GO:0036017) cellular response to erythropoietin(GO:0036018) |
| 0.4 | 0.4 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
| 0.4 | 2.9 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.4 | 4.9 | GO:0009757 | hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
| 0.4 | 0.8 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.4 | 2.5 | GO:0030421 | defecation(GO:0030421) |
| 0.4 | 1.6 | GO:0035864 | response to potassium ion(GO:0035864) |
| 0.4 | 12.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.4 | 1.2 | GO:1990922 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.4 | 3.2 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.4 | 0.8 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.4 | 3.2 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.4 | 1.2 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.4 | 8.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.4 | 0.4 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 0.4 | 2.0 | GO:0030222 | eosinophil differentiation(GO:0030222) |
| 0.4 | 3.9 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.4 | 0.4 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
| 0.4 | 0.4 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 0.4 | 13.5 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.4 | 1.9 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.4 | 1.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.4 | 0.4 | GO:0002880 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
| 0.4 | 2.3 | GO:0061744 | motor behavior(GO:0061744) |
| 0.4 | 1.9 | GO:0046898 | response to cycloheximide(GO:0046898) |
| 0.4 | 1.1 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.4 | 2.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.4 | 0.4 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.4 | 4.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.4 | 1.5 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.4 | 0.8 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 0.4 | 0.8 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
| 0.4 | 3.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.4 | 1.5 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.4 | 2.6 | GO:1901569 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.4 | 4.5 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.4 | 7.8 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
| 0.4 | 1.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 0.4 | 1.8 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.4 | 1.8 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.4 | 1.8 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.4 | 0.7 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.4 | 0.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.4 | 2.6 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 0.4 | 0.4 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
| 0.4 | 0.7 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.4 | 9.5 | GO:0031167 | rRNA methylation(GO:0031167) |
| 0.4 | 5.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.4 | 4.3 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.4 | 0.4 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 0.4 | 2.9 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.4 | 2.2 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.4 | 1.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.4 | 1.1 | GO:0043318 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
| 0.4 | 1.8 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.4 | 2.1 | GO:0021539 | subthalamus development(GO:0021539) |
| 0.4 | 1.4 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
| 0.4 | 2.5 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.4 | 2.1 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.4 | 0.4 | GO:0060788 | ectodermal placode formation(GO:0060788) hair follicle placode formation(GO:0060789) ectodermal placode morphogenesis(GO:0071697) |
| 0.4 | 3.2 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
| 0.4 | 1.1 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.4 | 2.8 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.4 | 0.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.4 | 2.5 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.4 | 1.1 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.4 | 4.2 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.4 | 8.4 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.3 | 2.1 | GO:0019427 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.3 | 1.0 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 0.3 | 0.7 | GO:0072034 | renal vesicle induction(GO:0072034) |
| 0.3 | 1.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.3 | 7.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.3 | 3.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
| 0.3 | 4.5 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.3 | 2.4 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 0.3 | 2.8 | GO:0045007 | depurination(GO:0045007) |
| 0.3 | 3.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.3 | 5.5 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.3 | 3.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.3 | 1.0 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.3 | 0.7 | GO:0061141 | lung ciliated cell differentiation(GO:0061141) |
| 0.3 | 1.0 | GO:0061580 | colon epithelial cell migration(GO:0061580) |
| 0.3 | 2.0 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.3 | 1.0 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 0.3 | 2.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.3 | 0.3 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
| 0.3 | 1.0 | GO:0021502 | neural fold elevation formation(GO:0021502) allantois development(GO:1905069) |
| 0.3 | 7.1 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.3 | 2.0 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
| 0.3 | 0.3 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.3 | 1.3 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.3 | 1.0 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.3 | 1.3 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.3 | 1.0 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.3 | 0.7 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
| 0.3 | 1.3 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.3 | 2.3 | GO:0014003 | oligodendrocyte development(GO:0014003) |
| 0.3 | 3.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.3 | 3.0 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
| 0.3 | 1.6 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.3 | 1.6 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 0.3 | 1.0 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.3 | 3.6 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.3 | 5.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.3 | 3.9 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
| 0.3 | 2.9 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.3 | 0.6 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.3 | 1.3 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
| 0.3 | 1.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.3 | 1.6 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.3 | 4.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.3 | 1.9 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.3 | 1.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.3 | 0.3 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.3 | 2.6 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.3 | 1.0 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.3 | 1.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.3 | 1.0 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.3 | 1.0 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.3 | 0.3 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
| 0.3 | 5.0 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
| 0.3 | 1.6 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.3 | 1.3 | GO:0021553 | olfactory nerve development(GO:0021553) |
| 0.3 | 1.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.3 | 16.0 | GO:0090662 | ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.3 | 1.9 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.3 | 0.6 | GO:0060214 | endocardium formation(GO:0060214) |
| 0.3 | 0.3 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.3 | 1.6 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.3 | 1.6 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.3 | 2.5 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.3 | 0.9 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
| 0.3 | 0.3 | GO:0035802 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
| 0.3 | 2.5 | GO:0008228 | opsonization(GO:0008228) |
| 0.3 | 0.3 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.3 | 1.2 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.3 | 0.6 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.3 | 1.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.3 | 0.9 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.3 | 3.6 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.3 | 3.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.3 | 3.6 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.3 | 2.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
| 0.3 | 1.8 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.3 | 5.7 | GO:0015886 | heme transport(GO:0015886) |
| 0.3 | 0.3 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.3 | 0.3 | GO:0003292 | cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 0.3 | 0.9 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.3 | 6.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.3 | 4.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.3 | 2.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.3 | 0.3 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.3 | 2.6 | GO:0009111 | vitamin catabolic process(GO:0009111) |
| 0.3 | 5.2 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.3 | 7.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.3 | 0.3 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.3 | 0.6 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.3 | 1.2 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.3 | 1.4 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 0.3 | 6.6 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.3 | 2.9 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.3 | 1.1 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.3 | 1.4 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.3 | 0.3 | GO:0002589 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.3 | 2.8 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.3 | 1.1 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.3 | 1.7 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.3 | 0.8 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.3 | 0.8 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 0.3 | 3.4 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 0.3 | 2.0 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.3 | 5.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.3 | 0.6 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
| 0.3 | 1.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.3 | 0.6 | GO:1902958 | detoxification of copper ion(GO:0010273) enzyme active site formation(GO:0018307) neuron death in response to hydrogen peroxide(GO:0036476) neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) detoxification of mercury ion(GO:0050787) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) stress response to copper ion(GO:1990169) regulation of cellular amino acid biosynthetic process(GO:2000282) |
| 0.3 | 1.1 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.3 | 0.6 | GO:0021589 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.3 | 0.5 | GO:1902065 | response to L-glutamate(GO:1902065) |
| 0.3 | 0.5 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.3 | 3.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.3 | 0.3 | GO:0045073 | regulation of chemokine biosynthetic process(GO:0045073) |
| 0.3 | 2.4 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.3 | 1.9 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.3 | 1.4 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
| 0.3 | 1.1 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.3 | 0.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.3 | 1.6 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.3 | 0.5 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.3 | 0.8 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.3 | 39.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.3 | 0.8 | GO:0035349 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.3 | 1.9 | GO:0060356 | leucine import(GO:0060356) |
| 0.3 | 0.5 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.3 | 0.5 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 0.3 | 1.3 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.3 | 3.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.3 | 0.5 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.3 | 4.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.3 | 0.3 | GO:2000790 | regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.3 | 8.2 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.3 | 1.6 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.3 | 0.8 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.3 | 5.2 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.3 | 0.5 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) |
| 0.3 | 1.6 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.3 | 1.8 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.3 | 1.0 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.3 | 2.1 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.3 | 0.8 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.3 | 1.8 | GO:0019075 | virus maturation(GO:0019075) |
| 0.3 | 1.8 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.3 | 1.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.3 | 2.5 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 0.3 | 3.8 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.3 | 4.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.3 | 0.5 | GO:1904861 | postsynaptic density assembly(GO:0097107) gephyrin clustering involved in postsynaptic density assembly(GO:0097116) excitatory synapse assembly(GO:1904861) |
| 0.3 | 1.5 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.2 | 1.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.2 | 0.2 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
| 0.2 | 10.4 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.2 | 4.2 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.2 | 1.7 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.2 | 1.2 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.2 | 0.7 | GO:0030070 | insulin processing(GO:0030070) |
| 0.2 | 2.5 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.2 | 5.1 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.2 | 3.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 0.2 | 3.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.2 | 3.2 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.2 | 2.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.2 | 0.5 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
| 0.2 | 0.5 | GO:1900166 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
| 0.2 | 0.2 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
| 0.2 | 3.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.2 | 5.7 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.2 | 0.5 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.2 | 8.8 | GO:0006735 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.2 | 0.7 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.2 | 27.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.2 | 1.2 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
| 0.2 | 0.5 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.2 | 1.9 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.2 | 0.5 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.2 | 0.7 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.2 | 17.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.2 | 4.9 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.2 | 2.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.2 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.2 | 0.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.2 | 0.9 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.2 | 0.2 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.2 | 3.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.2 | 1.4 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.2 | 3.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.2 | 2.1 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.2 | 0.5 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.2 | 4.1 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.2 | 2.0 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
| 0.2 | 2.0 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.2 | 1.4 | GO:0044650 | adhesion of symbiont to host cell(GO:0044650) |
| 0.2 | 0.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.2 | 1.6 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.2 | 0.7 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.2 | 0.5 | GO:0070945 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.2 | 0.2 | GO:0097106 | postsynaptic density organization(GO:0097106) |
| 0.2 | 1.1 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) |
| 0.2 | 2.2 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.2 | 0.7 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 0.2 | 0.9 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.2 | 4.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.2 | 0.9 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.2 | 4.9 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.2 | 4.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.2 | 0.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.2 | 0.4 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
| 0.2 | 6.1 | GO:0007625 | grooming behavior(GO:0007625) |
| 0.2 | 12.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.2 | 1.3 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.2 | 1.7 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.2 | 0.7 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.2 | 2.2 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.2 | 1.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.2 | 2.8 | GO:0044062 | regulation of excretion(GO:0044062) |
| 0.2 | 2.4 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.2 | 7.1 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
| 0.2 | 0.2 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
| 0.2 | 0.4 | GO:0045168 | cell-cell signaling involved in cell fate commitment(GO:0045168) |
| 0.2 | 0.9 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.2 | 7.5 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.2 | 1.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 | 6.2 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.2 | 1.1 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.2 | 0.4 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.2 | 2.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 | 1.5 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
| 0.2 | 1.7 | GO:0001774 | microglial cell activation(GO:0001774) |
| 0.2 | 1.7 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.2 | 0.8 | GO:0019401 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 0.2 | 0.2 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
| 0.2 | 0.6 | GO:2000395 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.2 | 1.3 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
| 0.2 | 0.6 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
| 0.2 | 2.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.2 | 1.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.2 | 0.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 0.2 | 0.8 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.2 | 0.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.2 | 0.4 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.2 | 0.8 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.2 | 0.2 | GO:1903093 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.2 | 3.9 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.2 | 1.2 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.2 | 1.0 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.2 | 1.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 | 1.4 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.2 | 2.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.2 | 2.4 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.2 | 0.6 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
| 0.2 | 0.6 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.2 | 1.2 | GO:0035799 | ureter maturation(GO:0035799) |
| 0.2 | 0.8 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.2 | 0.6 | GO:0034344 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.2 | 0.6 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.2 | 1.6 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.2 | 3.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.2 | 0.8 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.2 | 0.6 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.2 | 0.6 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.2 | 0.8 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 | 2.5 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
| 0.2 | 0.4 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.2 | 1.8 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
| 0.2 | 5.3 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.2 | 4.3 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.2 | 3.7 | GO:0032098 | regulation of appetite(GO:0032098) |
| 0.2 | 1.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.2 | 0.2 | GO:0042092 | type 2 immune response(GO:0042092) |
| 0.2 | 1.0 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.2 | 1.2 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.2 | 1.3 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.2 | 0.8 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.2 | 2.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.2 | 0.2 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
| 0.2 | 5.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.2 | 1.3 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.2 | 3.8 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.2 | 1.5 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.2 | 4.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.2 | 1.3 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.2 | 0.9 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.2 | 0.6 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.2 | 0.7 | GO:0098582 | innate vocalization behavior(GO:0098582) |
| 0.2 | 1.3 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.2 | 1.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 | 1.3 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.2 | 2.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.2 | 4.3 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.2 | 0.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
| 0.2 | 0.4 | GO:0071316 | cellular response to nicotine(GO:0071316) |
| 0.2 | 0.9 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.2 | 2.5 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
| 0.2 | 2.0 | GO:0021860 | pyramidal neuron development(GO:0021860) |
| 0.2 | 0.2 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.2 | 0.5 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.2 | 0.5 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.2 | 1.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.2 | 0.5 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.2 | 0.9 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.2 | 0.9 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.2 | 4.6 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.2 | 0.2 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) |
| 0.2 | 1.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.2 | 0.3 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
| 0.2 | 0.3 | GO:1903430 | negative regulation of cell maturation(GO:1903430) |
| 0.2 | 1.6 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.2 | 0.3 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.2 | 0.7 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
| 0.2 | 1.4 | GO:0044211 | CTP salvage(GO:0044211) |
| 0.2 | 5.5 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.2 | 2.6 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.2 | 1.0 | GO:0051715 | cytolysis in other organism(GO:0051715) |
| 0.2 | 0.2 | GO:1902617 | response to fluoride(GO:1902617) |
| 0.2 | 2.6 | GO:0097369 | sodium ion import(GO:0097369) |
| 0.2 | 0.3 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.2 | 0.5 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 0.2 | 1.0 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.2 | 1.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.2 | 2.5 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 | 0.3 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.2 | 0.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.2 | 0.7 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.2 | 0.7 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.2 | 0.3 | GO:0042335 | cuticle development(GO:0042335) |
| 0.2 | 2.3 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.2 | 1.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 | 1.1 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.2 | 0.8 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.2 | 1.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.2 | 0.7 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
| 0.2 | 1.0 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.2 | 1.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 | 1.1 | GO:0048663 | neuron fate commitment(GO:0048663) |
| 0.2 | 1.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.2 | 0.8 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.2 | 1.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.2 | 1.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.2 | 0.2 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
| 0.2 | 1.9 | GO:0044550 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) secondary metabolite biosynthetic process(GO:0044550) |
| 0.2 | 0.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.2 | 0.6 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.2 | 0.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.2 | 2.1 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.2 | 0.6 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.2 | 0.6 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.2 | 5.0 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.2 | 1.9 | GO:0060180 | female mating behavior(GO:0060180) |
| 0.2 | 0.2 | GO:2000851 | positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.2 | 3.3 | GO:0019835 | cytolysis(GO:0019835) |
| 0.2 | 0.6 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.2 | 1.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.2 | 0.3 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.2 | 0.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 | 0.5 | GO:0018012 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.2 | 2.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.2 | 1.6 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.2 | 1.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.2 | 0.5 | GO:0060829 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.2 | 1.2 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.2 | 0.9 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.2 | 2.3 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.2 | 1.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.2 | 1.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.2 | 0.5 | GO:0006598 | polyamine catabolic process(GO:0006598) |
| 0.2 | 3.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.2 | 1.5 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.2 | 0.9 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.1 | 1.6 | GO:0015747 | urate transport(GO:0015747) |
| 0.1 | 2.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.1 | 0.4 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.1 | 0.9 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.1 | 0.6 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.1 | 0.3 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
| 0.1 | 1.9 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.1 | 0.4 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 | 0.4 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.1 | 1.3 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
| 0.1 | 0.4 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.1 | 0.6 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.1 | 1.0 | GO:0098912 | membrane depolarization during AV node cell action potential(GO:0086045) membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 0.1 | 3.5 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 | 0.7 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.1 | 1.2 | GO:0045837 | negative regulation of membrane potential(GO:0045837) |
| 0.1 | 0.6 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.1 | 1.3 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.1 | 0.6 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 | 0.9 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.1 | 3.3 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
| 0.1 | 8.0 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.1 | 0.7 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.1 | 0.7 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 | 0.6 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.1 | 0.6 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.1 | 1.7 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.1 | 0.8 | GO:0021978 | telencephalon regionalization(GO:0021978) |
| 0.1 | 2.8 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.1 | 2.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.1 | 0.4 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 | 0.1 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.1 | 0.6 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 | 1.8 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.1 | 1.8 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.1 | 1.0 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.1 | 2.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 | 1.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 0.5 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.1 | 1.8 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.1 | 0.4 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.1 | 1.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 0.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 | 4.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 | 0.3 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.1 | 0.7 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.1 | 0.4 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 | 1.8 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.1 | 0.3 | GO:0060174 | limb bud formation(GO:0060174) |
| 0.1 | 0.4 | GO:0060381 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.1 | 0.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.1 | 0.5 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
| 0.1 | 0.7 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
| 0.1 | 2.7 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
| 0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.1 | 0.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 | 1.3 | GO:0048265 | response to pain(GO:0048265) |
| 0.1 | 0.5 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.1 | 0.4 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.1 | 2.4 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.1 | 1.8 | GO:0048557 | embryonic digestive tract morphogenesis(GO:0048557) |
| 0.1 | 0.4 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.1 | 0.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.1 | 0.4 | GO:1904616 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
| 0.1 | 0.5 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 | 0.9 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 | 0.5 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.1 | 2.1 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 | 0.5 | GO:0032474 | otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
| 0.1 | 0.2 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.1 | 0.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.1 | 1.7 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
| 0.1 | 0.4 | GO:0060431 | primary lung bud formation(GO:0060431) |
| 0.1 | 1.4 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.1 | 0.4 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 0.1 | 3.3 | GO:0097502 | mannosylation(GO:0097502) |
| 0.1 | 1.6 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 | 0.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 1.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.1 | 0.1 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 0.1 | 1.8 | GO:0006554 | lysine catabolic process(GO:0006554) |
| 0.1 | 11.8 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.1 | 0.5 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.1 | 0.1 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 0.1 | 0.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.1 | 7.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.1 | 0.5 | GO:0035377 | transepithelial water transport(GO:0035377) |
| 0.1 | 7.7 | GO:0002279 | mast cell activation involved in immune response(GO:0002279) mast cell degranulation(GO:0043303) |
| 0.1 | 1.2 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 | 0.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.1 | 0.8 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.1 | 1.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.1 | 0.6 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.1 | 1.0 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
| 0.1 | 0.3 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 | 1.6 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.1 | 0.7 | GO:1990834 | response to odorant(GO:1990834) |
| 0.1 | 0.5 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 | 0.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.1 | 0.5 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.1 | 0.2 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
| 0.1 | 0.9 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.1 | 0.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.1 | 0.8 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.1 | 1.1 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.1 | 0.7 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.1 | 0.7 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
| 0.1 | 0.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.1 | 0.4 | GO:1903859 | regulation of dendrite extension(GO:1903859) |
| 0.1 | 9.8 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
| 0.1 | 3.7 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
| 0.1 | 1.0 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 | 1.5 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.1 | 0.7 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
| 0.1 | 1.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.1 | 1.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.1 | 1.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.1 | 0.6 | GO:0051593 | response to folic acid(GO:0051593) |
| 0.1 | 0.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 | 0.6 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.1 | 0.1 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.1 | 0.4 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
| 0.1 | 4.1 | GO:0032570 | response to progesterone(GO:0032570) |
| 0.1 | 0.2 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.1 | 0.6 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
| 0.1 | 1.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.1 | 1.1 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
| 0.1 | 1.7 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 | 2.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.1 | 0.5 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 | 1.5 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 | 1.9 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.1 | 0.2 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
| 0.1 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.1 | 0.5 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.1 | 0.5 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.1 | 0.5 | GO:0048749 | compound eye development(GO:0048749) |
| 0.1 | 0.2 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.1 | 0.5 | GO:0071350 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
| 0.1 | 1.4 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 | 0.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 0.1 | 0.5 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.1 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
| 0.1 | 2.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.1 | 0.3 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
| 0.1 | 1.0 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 0.1 | 0.5 | GO:0006837 | serotonin transport(GO:0006837) serotonin uptake(GO:0051610) |
| 0.1 | 1.2 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
| 0.1 | 0.4 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.1 | 0.2 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.1 | 0.2 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.1 | 0.2 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.1 | 0.4 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
| 0.1 | 0.7 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
| 0.1 | 0.7 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.1 | 0.8 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
| 0.1 | 0.5 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
| 0.1 | 1.0 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.1 | 0.1 | GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
| 0.1 | 2.5 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.1 | 1.5 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
| 0.1 | 0.2 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
| 0.1 | 0.7 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.1 | 1.4 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 | 0.1 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.1 | 0.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.1 | 0.7 | GO:0001964 | startle response(GO:0001964) |
| 0.1 | 1.6 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
| 0.1 | 1.2 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 | 0.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
| 0.1 | 0.3 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 0.1 | 0.3 | GO:0061056 | sclerotome development(GO:0061056) |
| 0.1 | 0.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.1 | 1.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 | 2.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.1 | 0.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.1 | 0.3 | GO:0033319 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.1 | 0.8 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 | 3.4 | GO:0097503 | sialylation(GO:0097503) |
| 0.1 | 0.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.1 | 0.3 | GO:0051195 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.1 | 6.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.1 | 5.8 | GO:0006414 | translational elongation(GO:0006414) |
| 0.1 | 0.2 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 0.1 | 0.4 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
| 0.1 | 0.4 | GO:0046541 | saliva secretion(GO:0046541) |
| 0.1 | 1.1 | GO:0014870 | response to muscle inactivity(GO:0014870) |
| 0.1 | 0.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
| 0.1 | 1.6 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 | 2.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 | 0.2 | GO:1901383 | negative regulation of chorionic trophoblast cell proliferation(GO:1901383) |
| 0.1 | 0.8 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.1 | 0.8 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.1 | 0.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 | 0.9 | GO:0006584 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
| 0.1 | 0.7 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.1 | 0.2 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 | 0.3 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
| 0.1 | 1.5 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.1 | 1.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 | 0.6 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.1 | 2.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.1 | 0.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.1 | 0.3 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.1 | 0.3 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.1 | 0.3 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.1 | 7.7 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.1 | 0.1 | GO:0002877 | acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
| 0.1 | 0.4 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.1 | 0.8 | GO:0034620 | cellular response to unfolded protein(GO:0034620) |
| 0.1 | 0.4 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 0.1 | 0.2 | GO:0072284 | metanephric S-shaped body morphogenesis(GO:0072284) |
| 0.1 | 1.0 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 | 0.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.1 | 0.2 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.1 | 0.2 | GO:0072249 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.1 | 0.4 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
| 0.1 | 0.2 | GO:0051758 | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
| 0.1 | 0.5 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 | 0.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.1 | 3.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.1 | 0.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.1 | 0.1 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
| 0.1 | 0.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.1 | 0.2 | GO:0051963 | regulation of synapse assembly(GO:0051963) |
| 0.1 | 0.7 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.1 | 0.1 | GO:0006581 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.1 | 0.1 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 0.1 | 0.1 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.1 | 0.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
| 0.1 | 0.7 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 | 0.4 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
| 0.1 | 0.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.1 | 5.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.1 | 1.4 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.1 | 0.9 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 0.4 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) |
| 0.1 | 0.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 | 0.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
| 0.1 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.1 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.1 | 0.9 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 | 0.9 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.1 | 0.1 | GO:1902616 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.1 | 0.6 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
| 0.1 | 0.4 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.1 | 1.1 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.1 | 0.6 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.1 | 0.1 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.1 | 1.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 | 1.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.1 | 0.2 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
| 0.1 | 0.1 | GO:0042311 | vasodilation(GO:0042311) |
| 0.1 | 0.1 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
| 0.1 | 0.3 | GO:0006702 | androgen biosynthetic process(GO:0006702) progesterone metabolic process(GO:0042448) |
| 0.1 | 0.8 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.1 | 0.1 | GO:1901890 | positive regulation of cell junction assembly(GO:1901890) |
| 0.1 | 0.6 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
| 0.1 | 0.3 | GO:0014904 | myotube cell development(GO:0014904) |
| 0.1 | 0.1 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.1 | 0.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 | 0.9 | GO:0003417 | growth plate cartilage development(GO:0003417) |
| 0.1 | 0.2 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
| 0.1 | 0.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 | 4.9 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 | 0.2 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.1 | 0.3 | GO:0098810 | neurotransmitter reuptake(GO:0098810) |
| 0.1 | 0.2 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.1 | 0.8 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
| 0.1 | 0.9 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.1 | 0.2 | GO:1901535 | regulation of DNA demethylation(GO:1901535) |
| 0.1 | 1.6 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
| 0.1 | 0.8 | GO:0006547 | histidine metabolic process(GO:0006547) |
| 0.1 | 1.0 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.1 | 0.4 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.1 | 0.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 0.1 | 0.2 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
| 0.1 | 0.3 | GO:0003416 | endochondral bone growth(GO:0003416) |
| 0.1 | 0.8 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 3.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.1 | 0.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.1 | 0.3 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.1 | 0.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 | 0.2 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.1 | 0.1 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.1 | 0.2 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.1 | 0.4 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 | 1.4 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 | 0.1 | GO:2000667 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
| 0.1 | 0.4 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.1 | 0.5 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.1 | 0.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.1 | 0.2 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.1 | 2.1 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
| 0.1 | 0.3 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
| 0.1 | 0.1 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 0.1 | 0.2 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 | 0.8 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 | 1.4 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.1 | 1.2 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.1 | 1.0 | GO:0015844 | monoamine transport(GO:0015844) |
| 0.1 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.1 | 0.8 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
| 0.1 | 0.5 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.1 | 0.4 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.1 | 0.4 | GO:0030730 | sequestering of triglyceride(GO:0030730) |
| 0.1 | 0.7 | GO:0007588 | excretion(GO:0007588) |
| 0.1 | 0.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.1 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
| 0.1 | 1.2 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 | 2.6 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 | 0.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.1 | 0.2 | GO:0008216 | spermidine metabolic process(GO:0008216) |
| 0.1 | 0.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.1 | 1.2 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.1 | 0.4 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 | 0.8 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
| 0.1 | 0.1 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
| 0.1 | 0.5 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 | 0.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 | 1.3 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
| 0.1 | 0.4 | GO:0030238 | male sex determination(GO:0030238) |
| 0.1 | 0.3 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 | 0.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 | 1.4 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
| 0.1 | 1.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.0 | 0.6 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.0 | 0.3 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.0 | 0.5 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.0 | 1.7 | GO:0019915 | lipid storage(GO:0019915) |
| 0.0 | 0.9 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.0 | 0.2 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.0 | 0.7 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.0 | 0.9 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
| 0.0 | 0.4 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.0 | 0.3 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.0 | 0.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
| 0.0 | 0.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.0 | 0.2 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.0 | 0.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.0 | 0.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.0 | 0.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 | 1.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 | 0.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.0 | 0.2 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
| 0.0 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
| 0.0 | 0.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 | 0.2 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.0 | 1.1 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.0 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 0.0 | 0.3 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
| 0.0 | 0.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.0 | 0.2 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.0 | 0.4 | GO:0035878 | nail development(GO:0035878) |
| 0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
| 0.0 | 0.5 | GO:0015695 | organic cation transport(GO:0015695) |
| 0.0 | 0.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.0 | 0.5 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 | 0.1 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
| 0.0 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.0 | 0.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.0 | 0.1 | GO:0046056 | dADP metabolic process(GO:0046056) |
| 0.0 | 0.8 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 | 0.2 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
| 0.0 | 0.1 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 0.0 | 0.4 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.0 | 0.7 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 | 0.0 | GO:0006591 | ornithine metabolic process(GO:0006591) |
| 0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.0 | 0.1 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
| 0.0 | 0.6 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.0 | 0.1 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.0 | 0.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.0 | 0.1 | GO:0044362 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.0 | 0.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 | 0.1 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.0 | 1.2 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.0 | 0.1 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.0 | 0.1 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of terminal mannose on C branch(GO:0036510) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.0 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 | 0.3 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 | 0.2 | GO:0042255 | ribosome assembly(GO:0042255) |
| 0.0 | 0.2 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
| 0.0 | 1.2 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 | 0.4 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.0 | 0.1 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
| 0.0 | 0.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.0 | 0.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.0 | 1.2 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
| 0.0 | 0.2 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
| 0.0 | 0.2 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.0 | 0.1 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.0 | 0.2 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 0.0 | 0.1 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
| 0.0 | 0.2 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.0 | 0.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
| 0.0 | 0.5 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.0 | 0.1 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
| 0.0 | 0.1 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.0 | 0.2 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
| 0.0 | 0.3 | GO:0048665 | neuron fate specification(GO:0048665) |
| 0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 0.0 | 0.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 0.0 | 0.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
| 0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.0 | 0.5 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.0 | 0.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.0 | 0.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.0 | 0.3 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
| 0.0 | 0.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 0.0 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 0.0 | 0.4 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 | 0.9 | GO:0006836 | neurotransmitter transport(GO:0006836) |
| 0.0 | 0.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.0 | 0.3 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.0 | 0.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.0 | 0.3 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.0 | 0.2 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
| 0.0 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.0 | 0.5 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.0 | 0.1 | GO:1903010 | regulation of bone development(GO:1903010) |
| 0.0 | 0.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
| 0.0 | 0.4 | GO:0035082 | axoneme assembly(GO:0035082) |
| 0.0 | 0.3 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.0 | 0.0 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
| 0.0 | 0.2 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 | 0.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.0 | 0.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.0 | 0.1 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.0 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 | 0.1 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
| 0.0 | 0.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.0 | 0.2 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.0 | 1.4 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.0 | 0.1 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.0 | 0.0 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.0 | 0.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.0 | 0.2 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.0 | 0.2 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 | 0.3 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.0 | 0.3 | GO:0048713 | regulation of oligodendrocyte differentiation(GO:0048713) |
| 0.0 | 0.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
| 0.0 | 0.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.0 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.0 | 0.3 | GO:0036315 | cellular response to sterol(GO:0036315) |
| 0.0 | 0.4 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 | 0.1 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 | 0.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.0 | 0.1 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 | 0.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.0 | 0.5 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.0 | 0.2 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
| 0.0 | 0.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.0 | 0.0 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
| 0.0 | 0.1 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
| 0.0 | 0.1 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.0 | 0.1 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.0 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.0 | 0.0 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.0 | 0.0 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.0 | 0.1 | GO:0002572 | pro-T cell differentiation(GO:0002572) regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.0 | 0.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.0 | 0.1 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) |
| 0.0 | 0.4 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.0 | 0.0 | GO:1902232 | regulation of positive thymic T cell selection(GO:1902232) |
| 0.0 | 0.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 | 0.0 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
| 0.0 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.0 | 0.2 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.0 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.0 | 0.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.0 | 0.8 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
| 0.0 | 0.0 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.0 | 0.2 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
| 0.0 | 0.0 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.0 | 0.0 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 | 0.1 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.0 | 0.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
| 0.0 | 0.0 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.4 | 3.4 | GO:0044301 | climbing fiber(GO:0044301) |
| 2.3 | 7.0 | GO:0098855 | HCN channel complex(GO:0098855) |
| 2.3 | 20.4 | GO:0035976 | AP1 complex(GO:0035976) |
| 2.0 | 10.2 | GO:0070701 | mucus layer(GO:0070701) |
| 2.0 | 8.0 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 1.4 | 1.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 1.4 | 8.3 | GO:0071797 | LUBAC complex(GO:0071797) |
| 1.3 | 5.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 1.2 | 4.7 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 1.1 | 5.6 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 1.0 | 3.1 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 1.0 | 5.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 1.0 | 7.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 1.0 | 7.8 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.9 | 8.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.9 | 2.7 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.8 | 21.3 | GO:0042627 | chylomicron(GO:0042627) |
| 0.8 | 0.8 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 0.8 | 10.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.8 | 3.0 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 0.7 | 9.0 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.7 | 5.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.7 | 2.2 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.7 | 7.8 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.7 | 4.9 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.7 | 3.4 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.7 | 3.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.6 | 3.8 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.6 | 2.5 | GO:0097196 | Shu complex(GO:0097196) |
| 0.6 | 8.9 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.6 | 1.8 | GO:0030689 | Noc complex(GO:0030689) |
| 0.6 | 3.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.6 | 11.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.6 | 4.5 | GO:0097361 | CIA complex(GO:0097361) |
| 0.5 | 0.5 | GO:0016342 | catenin complex(GO:0016342) |
| 0.5 | 2.1 | GO:1990742 | microvesicle(GO:1990742) |
| 0.5 | 4.8 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.5 | 3.6 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.5 | 3.5 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.5 | 2.0 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.5 | 2.9 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.5 | 7.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.5 | 3.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
| 0.5 | 4.7 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.5 | 9.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.5 | 0.5 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.5 | 5.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.4 | 1.8 | GO:0044753 | amphisome(GO:0044753) |
| 0.4 | 21.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.4 | 0.9 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.4 | 3.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.4 | 9.4 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
| 0.4 | 4.1 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
| 0.4 | 4.9 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.4 | 1.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.4 | 3.2 | GO:1990393 | 3M complex(GO:1990393) |
| 0.4 | 2.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 0.4 | 2.0 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.4 | 9.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.4 | 1.6 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.4 | 5.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.4 | 0.8 | GO:0097413 | Lewy body(GO:0097413) |
| 0.4 | 2.3 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.4 | 0.4 | GO:0044393 | microspike(GO:0044393) |
| 0.4 | 3.3 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.4 | 1.1 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.4 | 2.5 | GO:0089701 | U2AF(GO:0089701) |
| 0.4 | 1.1 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
| 0.4 | 1.1 | GO:1990812 | growth cone filopodium(GO:1990812) |
| 0.3 | 0.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 0.3 | 5.2 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.3 | 1.0 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
| 0.3 | 1.7 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.3 | 1.7 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 0.3 | 3.4 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.3 | 3.4 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.3 | 3.0 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.3 | 1.7 | GO:0002133 | polycystin complex(GO:0002133) |
| 0.3 | 5.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.3 | 0.3 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.3 | 1.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.3 | 2.0 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.3 | 5.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.3 | 2.9 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.3 | 0.6 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
| 0.3 | 1.3 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.3 | 1.3 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.3 | 5.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.3 | 3.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.3 | 7.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.3 | 2.5 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 0.3 | 0.9 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.3 | 2.4 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 0.3 | 0.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.3 | 5.3 | GO:0005861 | troponin complex(GO:0005861) |
| 0.3 | 35.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.3 | 0.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.3 | 0.6 | GO:0032994 | protein-lipid complex(GO:0032994) |
| 0.3 | 7.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.3 | 2.9 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.3 | 10.1 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.3 | 4.7 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.3 | 1.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.3 | 1.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.3 | 0.3 | GO:0000806 | Y chromosome(GO:0000806) |
| 0.3 | 1.4 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.3 | 0.3 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.3 | 3.3 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.3 | 2.1 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.3 | 2.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.3 | 3.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.3 | 4.3 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.3 | 1.0 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.3 | 0.8 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.2 | 19.0 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.2 | 1.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.2 | 1.0 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
| 0.2 | 0.7 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.2 | 1.7 | GO:0042825 | TAP complex(GO:0042825) |
| 0.2 | 8.8 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.2 | 1.4 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.2 | 3.1 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.2 | 3.7 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.2 | 5.5 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.2 | 0.9 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.2 | 4.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.2 | 1.3 | GO:0032021 | NELF complex(GO:0032021) |
| 0.2 | 1.8 | GO:0043196 | varicosity(GO:0043196) |
| 0.2 | 0.7 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.2 | 2.2 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.2 | 1.7 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.2 | 16.1 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.2 | 0.6 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
| 0.2 | 3.2 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.2 | 1.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.2 | 4.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.2 | 1.2 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.2 | 2.5 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.2 | 0.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.2 | 0.6 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.2 | 0.2 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.2 | 6.7 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.2 | 1.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.2 | 8.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.2 | 1.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.2 | 1.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.2 | 6.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.2 | 18.0 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.2 | 0.6 | GO:0035101 | FACT complex(GO:0035101) |
| 0.2 | 0.7 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.2 | 2.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.2 | 0.9 | GO:0071547 | piP-body(GO:0071547) |
| 0.2 | 3.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.2 | 0.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.2 | 0.9 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.2 | 0.5 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.2 | 0.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.2 | 0.2 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.2 | 1.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 0.2 | 20.1 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.2 | 3.8 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.2 | 1.0 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.2 | 13.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.2 | 13.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.2 | 1.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.2 | 1.7 | GO:0000801 | central element(GO:0000801) |
| 0.2 | 2.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.2 | 0.5 | GO:0005883 | neurofilament(GO:0005883) |
| 0.2 | 2.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.2 | 0.6 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.2 | 0.6 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.2 | 0.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 0.2 | 1.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.2 | 0.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.2 | 0.8 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.2 | 5.0 | GO:0044453 | nuclear membrane part(GO:0044453) |
| 0.2 | 0.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.2 | 8.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 1.3 | GO:0022626 | cytosolic ribosome(GO:0022626) |
| 0.1 | 7.1 | GO:0031430 | M band(GO:0031430) |
| 0.1 | 2.9 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.1 | 0.6 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 0.1 | 2.0 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.1 | 2.4 | GO:0097433 | dense body(GO:0097433) |
| 0.1 | 1.5 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.1 | 1.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.1 | 0.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.1 | 0.8 | GO:0042025 | host cell nucleus(GO:0042025) |
| 0.1 | 0.3 | GO:0032982 | myosin filament(GO:0032982) |
| 0.1 | 1.1 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.1 | 0.9 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
| 0.1 | 1.4 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.1 | 0.5 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
| 0.1 | 2.3 | GO:0032059 | bleb(GO:0032059) |
| 0.1 | 0.9 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 0.1 | 0.1 | GO:0016528 | sarcoplasm(GO:0016528) |
| 0.1 | 0.6 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.1 | 1.3 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.1 | 1.2 | GO:0005638 | lamin filament(GO:0005638) |
| 0.1 | 5.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.1 | 2.5 | GO:0097346 | INO80-type complex(GO:0097346) |
| 0.1 | 1.1 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 1.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 0.3 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.1 | 1.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.1 | 5.8 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.1 | 0.1 | GO:0097179 | protease inhibitor complex(GO:0097179) |
| 0.1 | 2.3 | GO:0036038 | MKS complex(GO:0036038) |
| 0.1 | 4.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.1 | 3.3 | GO:0032590 | dendrite membrane(GO:0032590) |
| 0.1 | 0.2 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.1 | 0.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.1 | 0.7 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.1 | 0.4 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.1 | 2.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.1 | 0.8 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.1 | 0.1 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.1 | 3.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 0.7 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.1 | 0.1 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
| 0.1 | 1.7 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.1 | 1.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.1 | 1.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.1 | 8.5 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.1 | 1.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.1 | 0.5 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.1 | 0.8 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.1 | 0.5 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.1 | 0.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.1 | 0.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.1 | 5.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.1 | 0.8 | GO:0005858 | axonemal dynein complex(GO:0005858) |
| 0.1 | 2.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 1.1 | GO:0046930 | pore complex(GO:0046930) |
| 0.1 | 1.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.1 | 1.8 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.1 | 3.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.1 | 1.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.1 | 0.3 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.1 | 8.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.1 | 2.0 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.1 | 1.4 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.1 | 19.4 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.1 | 6.2 | GO:0015030 | Cajal body(GO:0015030) |
| 0.1 | 0.8 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.1 | 0.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.1 | 1.0 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.1 | 0.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.1 | 1.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.1 | 0.2 | GO:0035838 | growing cell tip(GO:0035838) |
| 0.1 | 2.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.1 | 0.2 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 0.1 | 0.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.1 | 0.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.1 | 1.0 | GO:0030681 | multimeric ribonuclease P complex(GO:0030681) |
| 0.1 | 0.7 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 1.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.1 | 9.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.1 | 0.2 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 0.1 | 0.3 | GO:0071546 | pi-body(GO:0071546) |
| 0.1 | 1.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 0.4 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.1 | 27.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.1 | 1.1 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.1 | 0.3 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 0.1 | 1.4 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 410.5 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.1 | 0.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.1 | 8.7 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.1 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.1 | 0.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.1 | 65.3 | GO:0005615 | extracellular space(GO:0005615) |
| 0.1 | 0.2 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.0 | 3.0 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 0.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.0 | 0.1 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.0 | 3.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 0.7 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.0 | 0.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.0 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
| 0.0 | 0.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.0 | 0.2 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.0 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.0 | 0.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.0 | 0.2 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.0 | 0.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.0 | 0.2 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.0 | 0.3 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
| 0.0 | 0.1 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.0 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.0 | 0.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.0 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.0 | 0.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.0 | 0.9 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.0 | 2.0 | GO:0030175 | filopodium(GO:0030175) |
| 0.0 | 0.1 | GO:0005713 | recombination nodule(GO:0005713) |
| 0.0 | 0.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.0 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
| 0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.9 | 8.8 | GO:0052894 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
| 2.6 | 7.9 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 2.5 | 7.5 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 2.1 | 6.4 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 1.9 | 5.7 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 1.9 | 5.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 1.8 | 5.4 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
| 1.7 | 6.8 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 1.6 | 4.8 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 1.5 | 6.1 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 1.5 | 9.1 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 1.5 | 4.5 | GO:0004103 | choline kinase activity(GO:0004103) |
| 1.5 | 1.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 1.5 | 4.4 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 1.5 | 7.3 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 1.4 | 8.6 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 1.4 | 8.5 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 1.4 | 4.2 | GO:0043337 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
| 1.4 | 5.5 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 1.4 | 6.8 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
| 1.3 | 6.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 1.3 | 8.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 1.3 | 3.9 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 1.3 | 2.6 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
| 1.3 | 3.8 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 1.2 | 6.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 1.2 | 5.0 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 1.2 | 4.9 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 1.2 | 3.6 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 1.2 | 4.7 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 1.2 | 3.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 1.1 | 5.7 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 1.1 | 6.8 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 1.1 | 3.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 1.1 | 3.3 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 1.1 | 13.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 1.1 | 11.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 1.1 | 3.3 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 1.1 | 3.2 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 1.1 | 3.2 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 1.1 | 12.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 1.1 | 8.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 1.0 | 3.0 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 1.0 | 3.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.9 | 8.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.9 | 4.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.9 | 2.8 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.9 | 11.2 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.9 | 4.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.9 | 2.8 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 0.9 | 3.7 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.9 | 6.4 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.9 | 6.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.9 | 1.8 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
| 0.9 | 2.6 | GO:0015131 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
| 0.8 | 2.5 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.8 | 2.5 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
| 0.8 | 4.2 | GO:0010736 | serum response element binding(GO:0010736) |
| 0.8 | 14.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.8 | 0.8 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.8 | 2.4 | GO:0070361 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
| 0.8 | 2.4 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
| 0.8 | 8.0 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
| 0.8 | 4.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.8 | 5.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.8 | 2.3 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.8 | 2.3 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.8 | 3.8 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.8 | 1.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.7 | 19.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.7 | 0.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.7 | 1.5 | GO:0002060 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
| 0.7 | 2.2 | GO:0032093 | SAM domain binding(GO:0032093) |
| 0.7 | 2.2 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
| 0.7 | 3.6 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.7 | 2.8 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.7 | 10.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.7 | 2.1 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.7 | 2.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
| 0.7 | 4.2 | GO:0016531 | copper chaperone activity(GO:0016531) |
| 0.7 | 4.9 | GO:0046979 | TAP2 binding(GO:0046979) |
| 0.7 | 2.8 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.7 | 2.1 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.7 | 3.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.7 | 2.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.7 | 4.7 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.7 | 2.0 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
| 0.7 | 2.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.7 | 9.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.7 | 2.0 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 0.6 | 1.9 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
| 0.6 | 2.5 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.6 | 3.1 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.6 | 4.3 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.6 | 3.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.6 | 2.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.6 | 1.8 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
| 0.6 | 4.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.6 | 1.8 | GO:0097259 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.6 | 1.8 | GO:0070698 | type I activin receptor binding(GO:0070698) |
| 0.6 | 2.3 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.6 | 1.7 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
| 0.6 | 2.3 | GO:0090556 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 0.6 | 8.0 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.6 | 4.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.6 | 5.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.6 | 1.1 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
| 0.6 | 5.6 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.6 | 5.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.5 | 2.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.5 | 2.2 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.5 | 1.6 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 0.5 | 2.2 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.5 | 2.7 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.5 | 1.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 0.5 | 2.1 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.5 | 3.7 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.5 | 2.1 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.5 | 2.0 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.5 | 2.0 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.5 | 1.5 | GO:0004458 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
| 0.5 | 4.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.5 | 2.0 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.5 | 1.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.5 | 0.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.5 | 14.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.5 | 2.9 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.5 | 5.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.5 | 0.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.5 | 4.7 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.5 | 2.8 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.5 | 1.4 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.5 | 0.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
| 0.5 | 1.8 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.5 | 1.4 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
| 0.5 | 4.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.5 | 1.8 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.5 | 1.4 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
| 0.5 | 3.6 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.4 | 1.8 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.4 | 1.8 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.4 | 3.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.4 | 1.8 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.4 | 14.9 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.4 | 3.5 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.4 | 1.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.4 | 5.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.4 | 0.4 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
| 0.4 | 1.7 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.4 | 2.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.4 | 2.1 | GO:0002046 | opsin binding(GO:0002046) |
| 0.4 | 1.7 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.4 | 12.8 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.4 | 2.5 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.4 | 1.2 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
| 0.4 | 0.4 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.4 | 4.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.4 | 1.2 | GO:0016730 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
| 0.4 | 1.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.4 | 1.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.4 | 0.8 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 0.4 | 3.9 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.4 | 3.1 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.4 | 3.9 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.4 | 1.2 | GO:0016250 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
| 0.4 | 15.7 | GO:0051183 | vitamin transporter activity(GO:0051183) |
| 0.4 | 3.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
| 0.4 | 1.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.4 | 2.6 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.4 | 1.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.4 | 3.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.4 | 4.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.4 | 1.1 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.4 | 8.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.4 | 8.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.4 | 1.1 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
| 0.4 | 10.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.4 | 4.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.4 | 3.9 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 0.4 | 12.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.4 | 2.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.4 | 1.1 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.3 | 2.4 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.3 | 1.0 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.3 | 5.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.3 | 1.0 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
| 0.3 | 4.4 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.3 | 1.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.3 | 3.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.3 | 3.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.3 | 3.4 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.3 | 1.3 | GO:0005019 | platelet-derived growth factor beta-receptor activity(GO:0005019) |
| 0.3 | 4.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.3 | 2.0 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.3 | 7.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.3 | 7.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.3 | 4.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.3 | 2.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.3 | 1.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.3 | 2.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.3 | 0.7 | GO:0048763 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
| 0.3 | 4.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.3 | 4.9 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.3 | 1.0 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.3 | 0.6 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.3 | 1.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.3 | 1.9 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.3 | 1.0 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.3 | 0.3 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 0.3 | 10.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.3 | 0.6 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.3 | 0.9 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.3 | 0.9 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.3 | 5.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.3 | 2.5 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.3 | 1.8 | GO:0070888 | E-box binding(GO:0070888) |
| 0.3 | 2.1 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
| 0.3 | 1.8 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.3 | 1.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.3 | 0.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.3 | 1.2 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.3 | 2.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.3 | 2.1 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
| 0.3 | 5.1 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.3 | 2.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.3 | 3.0 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 0.3 | 0.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.3 | 0.9 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.3 | 1.2 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
| 0.3 | 2.3 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.3 | 5.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.3 | 1.5 | GO:0042806 | fucose binding(GO:0042806) |
| 0.3 | 2.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.3 | 20.5 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.3 | 1.1 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.3 | 5.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.3 | 1.4 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 0.3 | 2.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.3 | 0.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.3 | 2.5 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.3 | 0.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.3 | 0.6 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 0.3 | 1.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.3 | 1.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.3 | 1.9 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 0.3 | 1.1 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.3 | 68.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.3 | 5.7 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.3 | 2.5 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.3 | 0.8 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
| 0.3 | 1.3 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.3 | 9.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.3 | 0.8 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.3 | 5.9 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.3 | 0.8 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
| 0.3 | 1.3 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.3 | 2.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.3 | 2.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.3 | 1.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.3 | 2.6 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 0.3 | 12.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.3 | 0.5 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
| 0.3 | 3.6 | GO:0008430 | selenium binding(GO:0008430) |
| 0.3 | 0.8 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.3 | 1.0 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.3 | 5.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.3 | 4.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.3 | 2.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.3 | 0.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.3 | 0.8 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.3 | 2.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.3 | 0.8 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.3 | 2.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.3 | 1.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.3 | 1.5 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.2 | 0.2 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 0.2 | 10.7 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.2 | 2.7 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.2 | 1.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.2 | 1.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.2 | 2.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.2 | 1.7 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.2 | 1.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
| 0.2 | 0.7 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.2 | 0.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.2 | 1.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.2 | 0.5 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.2 | 3.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 0.7 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
| 0.2 | 0.7 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 0.2 | 0.7 | GO:0052827 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol pentakisphosphate phosphatase activity(GO:0052827) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 0.2 | 7.6 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
| 0.2 | 0.9 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.2 | 1.4 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.2 | 2.4 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.2 | 0.9 | GO:0072545 | tyrosine binding(GO:0072545) |
| 0.2 | 3.0 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.2 | 6.3 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.2 | 2.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.2 | 1.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.2 | 5.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.2 | 4.4 | GO:0005537 | mannose binding(GO:0005537) |
| 0.2 | 0.2 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
| 0.2 | 0.7 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.2 | 0.5 | GO:0000701 | purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) |
| 0.2 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.2 | 0.9 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.2 | 1.6 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.2 | 1.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.2 | 1.8 | GO:0005534 | galactose binding(GO:0005534) |
| 0.2 | 4.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.2 | 0.7 | GO:0004040 | amidase activity(GO:0004040) |
| 0.2 | 0.6 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.2 | 0.9 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 0.2 | 1.5 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.2 | 0.6 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 0.2 | 2.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.2 | 0.6 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.2 | 2.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
| 0.2 | 1.1 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.2 | 0.6 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.2 | 1.5 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.2 | 2.9 | GO:0089720 | caspase binding(GO:0089720) |
| 0.2 | 0.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
| 0.2 | 0.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.2 | 2.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.2 | 1.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.2 | 0.6 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.2 | 0.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.2 | 0.8 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
| 0.2 | 4.0 | GO:0008061 | chitin binding(GO:0008061) |
| 0.2 | 2.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.2 | 2.6 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.2 | 2.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.2 | 0.6 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.2 | 4.0 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.2 | 0.6 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
| 0.2 | 2.0 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.2 | 4.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.2 | 1.0 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.2 | 1.0 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 0.2 | 0.8 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.2 | 0.6 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.2 | 6.4 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.2 | 6.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
| 0.2 | 0.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.2 | 0.8 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.2 | 0.6 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 0.2 | 1.8 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.2 | 0.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
| 0.2 | 1.8 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.2 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
| 0.2 | 4.1 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
| 0.2 | 0.4 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.2 | 0.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.2 | 1.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.2 | 1.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.2 | 2.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.2 | 0.6 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.2 | 0.8 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.2 | 22.8 | GO:0005179 | hormone activity(GO:0005179) |
| 0.2 | 0.4 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
| 0.2 | 1.5 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.2 | 4.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.2 | 2.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
| 0.2 | 4.2 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.2 | 2.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.2 | 1.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.2 | 1.9 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.2 | 1.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.2 | 0.7 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 0.2 | 3.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.2 | 0.9 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.2 | 2.7 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.2 | 1.8 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.2 | 2.2 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.2 | 1.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.2 | 0.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.2 | 2.0 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.2 | 3.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.2 | 2.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.2 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.2 | 4.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.2 | 1.9 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.2 | 0.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.2 | 1.7 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.2 | 0.7 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
| 0.2 | 1.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.2 | 3.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.2 | 0.7 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.2 | 2.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 0.2 | 1.4 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.2 | 2.6 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.2 | 1.5 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
| 0.2 | 0.8 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.2 | 1.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.2 | 1.2 | GO:0070513 | death domain binding(GO:0070513) |
| 0.2 | 1.0 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.2 | 3.7 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.2 | 1.0 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.2 | 4.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.2 | 0.7 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.2 | 0.5 | GO:0031071 | cysteine desulfurase activity(GO:0031071) |
| 0.2 | 1.6 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.2 | 0.5 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 0.2 | 1.5 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.2 | 1.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.2 | 6.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.2 | 2.1 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.2 | 23.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.2 | 0.8 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.2 | 0.6 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
| 0.2 | 1.4 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.2 | 2.9 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.2 | 1.8 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
| 0.2 | 3.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.2 | 1.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.2 | 0.5 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.2 | 0.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.2 | 0.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.2 | 2.2 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
| 0.2 | 0.5 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.2 | 0.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.2 | 0.5 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.2 | 0.6 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.2 | 0.5 | GO:0016855 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.2 | 1.8 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 0.2 | 2.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.2 | 0.5 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 0.2 | 5.0 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
| 0.2 | 1.5 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
| 0.2 | 0.5 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
| 0.2 | 0.8 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.2 | 1.1 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.2 | 1.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.2 | 0.8 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.2 | 1.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.2 | 2.4 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.2 | 0.6 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
| 0.2 | 1.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.2 | 1.1 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
| 0.2 | 1.5 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.2 | 0.8 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.2 | 2.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.2 | 2.1 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.1 | 0.4 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
| 0.1 | 1.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.1 | 0.9 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.1 | 2.2 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.1 | 2.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 0.6 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
| 0.1 | 0.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.1 | 0.4 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 0.1 | 0.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.1 | 2.1 | GO:0015925 | galactosidase activity(GO:0015925) |
| 0.1 | 1.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.1 | 2.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.1 | 1.4 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.1 | 0.3 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.1 | 1.1 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.1 | 0.6 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.1 | 3.3 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.1 | 2.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.1 | 0.4 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.1 | 1.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.1 | 0.4 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.1 | 1.1 | GO:0022821 | calcium, potassium:sodium antiporter activity(GO:0008273) potassium ion antiporter activity(GO:0022821) |
| 0.1 | 0.3 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.1 | 0.8 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.1 | 0.7 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 0.1 | 0.7 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.1 | 62.5 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.1 | 0.4 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.1 | 0.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.1 | 1.2 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.1 | 0.7 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 0.1 | 0.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.1 | 9.8 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.1 | 0.4 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.1 | 0.4 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 0.1 | 0.6 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.1 | 1.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.1 | 2.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.1 | 1.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.1 | 0.4 | GO:0035514 | DNA demethylase activity(GO:0035514) |
| 0.1 | 0.9 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.1 | 4.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.1 | 0.1 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.1 | 3.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.1 | 0.4 | GO:0051184 | cofactor transporter activity(GO:0051184) |
| 0.1 | 1.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.1 | 0.9 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 0.1 | 4.0 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.1 | 2.7 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.1 | 0.5 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.1 | 0.5 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.1 | 2.8 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 0.7 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.1 | 0.5 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
| 0.1 | 1.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.1 | 1.0 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.1 | 1.5 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.1 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.1 | 0.3 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
| 0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.1 | 3.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.1 | 4.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 0.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.1 | 0.5 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.1 | 2.8 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.1 | 1.9 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.1 | 1.0 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.1 | 0.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.1 | 4.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 0.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.1 | 1.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
| 0.1 | 5.9 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.1 | 1.0 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.1 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.1 | 0.6 | GO:0048185 | activin binding(GO:0048185) |
| 0.1 | 0.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.1 | 0.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.1 | 2.9 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 0.4 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) |
| 0.1 | 0.3 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 0.1 | 1.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.1 | 0.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.1 | 4.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.1 | 7.0 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.1 | 3.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 6.0 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 0.1 | 0.7 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.1 | 0.4 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.1 | 0.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.1 | 1.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.1 | 0.2 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.1 | 0.1 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.1 | 0.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.1 | 0.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.1 | 0.4 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.1 | 1.4 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.1 | 5.7 | GO:0001159 | core promoter proximal region DNA binding(GO:0001159) |
| 0.1 | 0.7 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.1 | 0.9 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.1 | 0.3 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
| 0.1 | 1.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.1 | 1.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 0.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.1 | 0.4 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.1 | 0.8 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.1 | 0.4 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
| 0.1 | 2.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 1.3 | GO:0001012 | RNA polymerase II regulatory region DNA binding(GO:0001012) |
| 0.1 | 0.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.1 | 4.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 2.6 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.1 | 3.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 0.8 | GO:0016594 | glycine binding(GO:0016594) |
| 0.1 | 1.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.1 | 0.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.1 | 0.6 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.1 | 1.7 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.1 | 0.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.1 | 2.0 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.1 | 2.1 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.1 | 0.3 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
| 0.1 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.1 | 2.3 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.1 | 0.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.1 | 1.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.1 | 0.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.1 | 0.2 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.1 | 0.5 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 0.1 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.1 | 0.8 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
| 0.1 | 0.2 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.1 | 0.9 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.1 | 2.6 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.1 | 2.0 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.1 | 3.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.1 | 0.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.1 | 0.2 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.1 | 0.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.1 | 0.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.1 | 0.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.1 | 0.1 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.1 | 0.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.1 | 0.2 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
| 0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.1 | 0.4 | GO:0000403 | Y-form DNA binding(GO:0000403) |
| 0.1 | 1.2 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.1 | 0.3 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.1 | 6.0 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.1 | 0.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
| 0.1 | 0.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.1 | 1.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 0.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.1 | 1.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.1 | 0.5 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
| 0.1 | 1.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.1 | 0.6 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.1 | 0.4 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.1 | 0.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.1 | 0.3 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
| 0.1 | 1.7 | GO:0015297 | antiporter activity(GO:0015297) |
| 0.1 | 0.5 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.1 | 1.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 0.2 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
| 0.1 | 0.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.1 | 1.6 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.1 | 1.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 0.5 | GO:0015250 | water channel activity(GO:0015250) |
| 0.1 | 0.2 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.1 | 0.6 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.1 | 0.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.1 | 0.2 | GO:0047946 | glutamine N-acyltransferase activity(GO:0047946) |
| 0.1 | 0.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.1 | 0.3 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.1 | 0.3 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
| 0.1 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 8.9 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.1 | 1.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.1 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.1 | 0.3 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 0.1 | 1.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.1 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.1 | 1.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.1 | 0.4 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.1 | 1.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.1 | 0.2 | GO:0016499 | orexin receptor activity(GO:0016499) |
| 0.0 | 0.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.0 | 0.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.0 | 0.1 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
| 0.0 | 0.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.0 | 0.2 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.0 | 0.8 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.0 | 3.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.0 | 3.9 | GO:0051213 | dioxygenase activity(GO:0051213) |
| 0.0 | 6.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.0 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.0 | 2.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.0 | 0.4 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.0 | 0.1 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.0 | 0.2 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.0 | 0.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 0.0 | 0.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.0 | 0.2 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 0.0 | 0.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.0 | 2.9 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
| 0.0 | 2.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.0 | 0.3 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
| 0.0 | 1.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.0 | 1.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.0 | 11.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.0 | 0.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.0 | 0.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.0 | 0.3 | GO:0016801 | adenosylhomocysteinase activity(GO:0004013) hydrolase activity, acting on ether bonds(GO:0016801) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.0 | 0.3 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.0 | 0.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.0 | 0.4 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.0 | 0.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.0 | 0.5 | GO:0005231 | excitatory extracellular ligand-gated ion channel activity(GO:0005231) |
| 0.0 | 1.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.0 | 0.2 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.0 | 0.1 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
| 0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.0 | 0.2 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.0 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.0 | 0.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
| 0.0 | 0.1 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 0.0 | 0.3 | GO:0010851 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
| 0.0 | 0.1 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.0 | 1.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 0.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.0 | 0.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.0 | 2.8 | GO:0005518 | collagen binding(GO:0005518) |
| 0.0 | 0.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.0 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.0 | 0.1 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
| 0.0 | 0.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.0 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.0 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
| 0.0 | 0.7 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.0 | 0.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.0 | 0.3 | GO:0019865 | immunoglobulin binding(GO:0019865) |
| 0.0 | 0.6 | GO:0031432 | titin binding(GO:0031432) |
| 0.0 | 3.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.0 | 1.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.0 | 7.7 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.0 | 0.5 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.0 | 0.2 | GO:0031404 | chloride ion binding(GO:0031404) |
| 0.0 | 0.1 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.0 | 2.1 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.0 | 0.1 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.0 | 0.2 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
| 0.0 | 0.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.0 | 0.3 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.0 | 0.3 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.0 | 0.2 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.0 | 0.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.0 | 0.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.0 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 0.3 | GO:0005549 | odorant binding(GO:0005549) |
| 0.0 | 0.1 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 0.0 | 0.0 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
| 0.0 | 2.1 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.0 | 0.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.0 | 0.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.0 | 0.0 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
| 0.0 | 0.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.0 | 0.0 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
| 0.0 | 0.0 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
| 0.0 | 4.6 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
| 0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.0 | 0.1 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.0 | 0.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.0 | 0.1 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
| 0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.0 | 0.0 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.0 | 0.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.0 | 0.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.0 | 0.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.0 | 0.1 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 3.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.4 | 0.9 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.4 | 8.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.4 | 1.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.3 | 2.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.3 | 8.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.3 | 3.8 | PID EPO PATHWAY | EPO signaling pathway |
| 0.2 | 9.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.2 | 0.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.2 | 2.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.2 | 14.8 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.2 | 13.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.2 | 16.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.2 | 12.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.2 | 6.2 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.2 | 0.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.2 | 77.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.2 | 3.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.2 | 4.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.1 | 13.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 3.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.1 | 14.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.1 | 3.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.1 | 0.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.1 | 1.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.1 | 7.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.1 | 1.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
| 0.1 | 10.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 1.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.1 | 0.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.1 | 4.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.1 | 1.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.1 | 1.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 2.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 2.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 5.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 1.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.1 | 5.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 27.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.1 | 2.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.1 | 1.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.1 | 18.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 1.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.1 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.1 | 2.8 | PID FGF PATHWAY | FGF signaling pathway |
| 0.1 | 4.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.1 | 4.1 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 2.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.1 | 17.4 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
| 0.0 | 1.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.0 | 3.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 1.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 1.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.0 | 1.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.0 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.0 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.0 | 0.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.0 | 1.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.0 | 0.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.0 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.0 | 0.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.0 | 0.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.0 | 0.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.0 | 0.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.0 | 0.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.0 | 2.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 0.5 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.0 | 0.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.0 | 1.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 0.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.0 | 0.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.0 | 0.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 9.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.6 | 5.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.5 | 11.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.5 | 11.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.5 | 2.9 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.5 | 10.9 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.5 | 8.7 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.4 | 13.7 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
| 0.4 | 7.9 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
| 0.4 | 7.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.4 | 36.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.4 | 9.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.4 | 8.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.4 | 8.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.4 | 5.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.3 | 3.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.3 | 5.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.3 | 8.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.3 | 55.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.3 | 10.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.3 | 24.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.3 | 15.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.3 | 5.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.3 | 9.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.3 | 4.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.3 | 9.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.3 | 19.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.3 | 26.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.3 | 0.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.3 | 22.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.3 | 7.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.3 | 6.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.3 | 1.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.3 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.2 | 4.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.2 | 4.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.2 | 3.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.2 | 3.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.2 | 14.3 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
| 0.2 | 5.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.2 | 3.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.2 | 2.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.2 | 4.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.2 | 6.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.2 | 0.6 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
| 0.2 | 14.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.2 | 2.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.2 | 3.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.2 | 15.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.2 | 2.4 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
| 0.2 | 5.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.2 | 3.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.2 | 5.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.2 | 12.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.2 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.2 | 5.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.2 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.2 | 2.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.2 | 1.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.2 | 12.5 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.2 | 10.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.2 | 1.5 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.2 | 7.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.2 | 4.0 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.1 | 2.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.1 | 1.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.1 | 4.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.1 | 7.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.1 | 3.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.1 | 4.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
| 0.1 | 6.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.1 | 1.8 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.1 | 1.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.1 | 4.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.1 | 5.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.1 | 4.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.1 | 1.6 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
| 0.1 | 1.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.1 | 1.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.1 | 2.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.1 | 1.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.1 | 2.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.1 | 9.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.1 | 2.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.1 | 0.4 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.1 | 2.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.1 | 3.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.1 | 6.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.1 | 2.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.1 | 3.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 6.4 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
| 0.1 | 3.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.1 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.1 | 1.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 2.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.1 | 4.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.1 | 1.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.1 | 1.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 1.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.1 | 1.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.1 | 1.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.1 | 0.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.1 | 3.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.1 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.1 | 10.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.1 | 2.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.1 | 1.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.1 | 8.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 1.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.1 | 2.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 0.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.1 | 0.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.1 | 0.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.1 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.1 | 0.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.1 | 2.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 2.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.1 | 1.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 0.1 | REACTOME M G1 TRANSITION | Genes involved in M/G1 Transition |
| 0.1 | 1.6 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.1 | 1.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.0 | 0.7 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.0 | 1.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.0 | 0.9 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.0 | 0.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.0 | 2.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.0 | 1.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.0 | 2.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.0 | 0.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.0 | 0.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.0 | 0.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.0 | 0.4 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
| 0.0 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.0 | 0.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.0 | 1.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.0 | 1.5 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.0 | 3.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.0 | 0.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.0 | 0.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 0.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.0 | 0.8 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.0 | 0.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 2.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 0.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.0 | 0.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 0.0 | 0.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |